<?xml version="1.0" encoding="UTF-8"?><OAI-PMH
	xmlns="http://www.openarchives.org/OAI/2.0/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/ http://www.openarchives.org/OAI/2.0/OAI-PMH.xsd"><responseDate>2019-03-02T19:44:07Z</responseDate><request verb="GetRecord" identifier="oai:pubmedcentral.nih.gov:3335791" metadataPrefix="pmc">https:/www.ncbi.nlm.nih.gov/pmc/oai/oai.cgi</request><GetRecord><record><header><identifier>oai:pubmedcentral.nih.gov:3335791</identifier><datestamp>2012-04-27</datestamp><setSpec>plosone</setSpec><setSpec>pmc-open</setSpec></header><metadata><article xmlns="https://jats.nlm.nih.gov/ns/archiving/1.0/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xsi:schemaLocation="https://jats.nlm.nih.gov/ns/archiving/1.0/ https://jats.nlm.nih.gov/archiving/1.0/xsd/JATS-archivearticle1.xsd" article-type="research-article">
  <front>
    <journal-meta>
      <journal-id journal-id-type="nlm-ta">PLoS One</journal-id>
      <journal-id journal-id-type="iso-abbrev">PLoS ONE</journal-id>
      <journal-id journal-id-type="publisher-id">plos</journal-id>
      <journal-id journal-id-type="pmc">plosone</journal-id>
      <journal-title-group>
        <journal-title>PLoS ONE</journal-title>
      </journal-title-group>
      <issn pub-type="epub">1932-6203</issn>
      <publisher>
        <publisher-name>Public Library of Science</publisher-name>
        <publisher-loc>San Francisco, USA</publisher-loc>
      </publisher>
    </journal-meta>
    <article-meta>
      <article-id pub-id-type="accession">PMC3335791</article-id>
      <article-id pub-id-type="pmcid">PMC3335791</article-id>
      <article-id pub-id-type="pmc-uid">3335791</article-id>
      <article-id pub-id-type="pmid">22545135</article-id>
      <article-id pub-id-type="pmid">22545135</article-id>
      <article-id pub-id-type="publisher-id">PONE-D-11-24551</article-id>
      <article-id pub-id-type="doi">10.1371/journal.pone.0035773</article-id>
      <article-categories>
        <subj-group subj-group-type="heading">
          <subject>Research Article</subject>
        </subj-group>
        <subj-group subj-group-type="Discipline-v2">
          <subject>Biology</subject>
          <subj-group>
            <subject>Computational Biology</subject>
            <subj-group>
              <subject>Population Genetics</subject>
              <subj-group>
                <subject>Mutation</subject>
              </subj-group>
            </subj-group>
          </subj-group>
          <subj-group>
            <subject>Genetics</subject>
            <subj-group>
              <subject>Human Genetics</subject>
              <subj-group>
                <subject>Autosomal Dominant</subject>
              </subj-group>
            </subj-group>
            <subj-group>
              <subject>Population Genetics</subject>
              <subj-group>
                <subject>Genetic Polymorphism</subject>
                <subject>Mutation</subject>
              </subj-group>
            </subj-group>
            <subj-group>
              <subject>Genetic Mutation</subject>
              <subject>Genetics of Disease</subject>
            </subj-group>
          </subj-group>
        </subj-group>
        <subj-group subj-group-type="Discipline-v2">
          <subject>Medicine</subject>
          <subj-group>
            <subject>Cardiovascular</subject>
            <subj-group>
              <subject>Venous Thromboembolism</subject>
            </subj-group>
          </subj-group>
          <subj-group>
            <subject>Hematology</subject>
            <subj-group>
              <subject>Coagulation disorders</subject>
              <subj-group>
                <subject>Protein C deficiency</subject>
              </subj-group>
            </subj-group>
          </subj-group>
        </subj-group>
      </article-categories>
      <title-group>
        <article-title>Genetic Background Analysis of Protein C Deficiency Demonstrates a Recurrent Mutation Associated with Venous Thrombosis in Chinese Population</article-title>
        <alt-title alt-title-type="running-head">Genetic Background of PC Deficiency in Chinese</alt-title>
      </title-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name>
            <surname>Tang</surname>
            <given-names>Liang</given-names>
          </name>
          <xref ref-type="aff" rid="aff1">
<sup>1</sup>
</xref>
          <xref ref-type="aff" rid="aff2">
<sup>2</sup>
</xref>
          <xref ref-type="aff" rid="aff3">
<sup>3</sup>
</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Guo</surname>
            <given-names>Tao</given-names>
          </name>
          <xref ref-type="aff" rid="aff1">
<sup>1</sup>
</xref>
          <xref ref-type="aff" rid="aff2">
<sup>2</sup>
</xref>
          <xref ref-type="aff" rid="aff3">
<sup>3</sup>
</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Yang</surname>
            <given-names>Rui</given-names>
          </name>
          <xref ref-type="aff" rid="aff1">
<sup>1</sup>
</xref>
          <xref ref-type="aff" rid="aff2">
<sup>2</sup>
</xref>
          <xref ref-type="aff" rid="aff3">
<sup>3</sup>
</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Mei</surname>
            <given-names>Heng</given-names>
          </name>
          <xref ref-type="aff" rid="aff1">
<sup>1</sup>
</xref>
          <xref ref-type="aff" rid="aff2">
<sup>2</sup>
</xref>
          <xref ref-type="aff" rid="aff3">
<sup>3</sup>
</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Wang</surname>
            <given-names>Huafang</given-names>
          </name>
          <xref ref-type="aff" rid="aff1">
<sup>1</sup>
</xref>
          <xref ref-type="aff" rid="aff2">
<sup>2</sup>
</xref>
          <xref ref-type="aff" rid="aff3">
<sup>3</sup>
</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Lu</surname>
            <given-names>Xuan</given-names>
          </name>
          <xref ref-type="aff" rid="aff1">
<sup>1</sup>
</xref>
          <xref ref-type="aff" rid="aff2">
<sup>2</sup>
</xref>
          <xref ref-type="aff" rid="aff3">
<sup>3</sup>
</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Yu</surname>
            <given-names>Jianming</given-names>
          </name>
          <xref ref-type="aff" rid="aff1">
<sup>1</sup>
</xref>
          <xref ref-type="aff" rid="aff2">
<sup>2</sup>
</xref>
          <xref ref-type="aff" rid="aff3">
<sup>3</sup>
</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Wang</surname>
            <given-names>Qingyun</given-names>
          </name>
          <xref ref-type="aff" rid="aff1">
<sup>1</sup>
</xref>
          <xref ref-type="aff" rid="aff2">
<sup>2</sup>
</xref>
          <xref ref-type="aff" rid="aff3">
<sup>3</sup>
</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Hu</surname>
            <given-names>Yu</given-names>
          </name>
          <xref ref-type="aff" rid="aff1">
<sup>1</sup>
</xref>
          <xref ref-type="aff" rid="aff2">
<sup>2</sup>
</xref>
          <xref ref-type="aff" rid="aff3">
<sup>3</sup>
</xref>
          <xref ref-type="corresp" rid="cor1">
<sup>*</sup>
</xref>
        </contrib>
      </contrib-group>
      <aff id="aff1">
<label>1</label>
<addr-line>Institute of Hematology, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, Hubei, People's Republic of China</addr-line>
</aff>
      <aff id="aff2">
<label>2</label>
<addr-line>Hubei Clinical and Research Center of Thrombosis and Hemostasis, Wuhan, Hubei, People's Republic of China</addr-line>
</aff>
      <aff id="aff3">
<label>3</label>
<addr-line>Targeted Biotherapy Key Laboratory of Ministry of Education, Wuhan, Hubei, People's Republic of China</addr-line>
</aff>
      <contrib-group>
        <contrib contrib-type="editor">
          <name>
            <surname>Reitsma</surname>
            <given-names>Pieter H.</given-names>
          </name>
          <role>Editor</role>
          <xref ref-type="aff" rid="edit1"/>
        </contrib>
      </contrib-group>
      <aff id="edit1">Leiden University Medical Center, The Netherlands</aff>
      <author-notes>
        <corresp id="cor1">* E-mail: <email>dr_huyu@126.com</email></corresp>
        <fn fn-type="con">
          <p>Conceived and designed the experiments: YH LT. Performed the experiments: LT RY XL JY. Analyzed the data: LT QW TG HW HM. Contributed reagents/materials/analysis tools: LT RY TG. Wrote the paper: LT JY TG HM.</p>
        </fn>
      </author-notes>
      <pub-date pub-type="collection">
        <year>2012</year>
      </pub-date>
      <pub-date pub-type="epub">
        <day>24</day>
        <month>4</month>
        <year>2012</year>
      </pub-date>
      <volume>7</volume>
      <issue>4</issue>
      <elocation-id>e35773</elocation-id>
      <history>
        <date date-type="received">
          <day>7</day>
          <month>12</month>
          <year>2011</year>
        </date>
        <date date-type="accepted">
          <day>21</day>
          <month>3</month>
          <year>2012</year>
        </date>
      </history>
      <permissions>
        <copyright-statement>Tang et al.</copyright-statement>
        <copyright-year>2012</copyright-year>
        <license xlink:href="http://creativecommons.org/licenses/by/4.0/">
          <license-p>This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are properly credited.</license-p>
        </license>
      </permissions>
      <abstract>
        <sec>
          <title>Background</title>
          <p>Protein C (PC) is one of the most important physiological inhibitors of coagulation proteases. Hereditary PC deficiency causes a predisposition to venous thrombosis (VT). The genetic characteristics of PC deficiency in the Chinese population remain unknown.</p>
        </sec>
        <sec>
          <title>Methods</title>
          <p>Thirty-four unrelated probands diagnosed with hereditary PC deficiency were investigated. PC activity and antigen levels were measured. Mutation analysis was performed by sequencing the <italic>PROC</italic> gene. <italic>In silico</italic> analyses, including PolyPhen-2, SIFT, multiple sequence alignment, splicing prediction, and protein molecular modeling were performed to predict the consequences of each variant identified. One recurrent mutation and its relative risk for thrombosis in relatives were analyzed in 11 families. The recurrent mutation was subsequently detected in a case (VT patients)-control study, and the adjusted odds ratio (OR) for VT risk was calculated by logistic regression analysis.</p>
        </sec>
        <sec>
          <title>Results</title>
          <p>A total of 18 different mutations, including 12 novel variants, were identified. One common mutation, <italic>PROC</italic> c.565C&gt;T (rs146922325:C&gt;T), was found in 17 of the 34 probands. The family study showed that first-degree relatives bearing this variant had an 8.8-fold (95%CIâ=â1.1â71.6) increased risk of venous thrombosis. The case-control (1003 vs. 1031) study identified this mutation in 5.88% patients and in 0.87% controls, respectively. The mutant allele conferred a high predisposition to venous thrombosis (adjusted ORâ=â7.34, 95%CIâ=â3.61â14.94). The plasma PC activity and antigen levels in heterozygotes were 51.73Â±6.92 U/dl and 75.17Â±4.84 U/dl, respectively.</p>
        </sec>
        <sec>
          <title>Conclusions</title>
          <p>This is the first study on the genetic background of PC deficiency in the Chinese population. The <italic>PROC</italic> c.565C&gt;T mutation is the most frequent cause of PC deficiency as well as a prevalent risk factor for VT in Chinese individuals. The inclusion of this variant in routine thrombophilic detection may improve the diagnosis and prevention of venous thrombosis.</p>
        </sec>
      </abstract>
      <counts>
        <page-count count="9"/>
      </counts>
    </article-meta>
  </front>
  <body>
    <sec id="s1">
      <title>Introduction</title>
      <p>Protein C, the key component of the PC anticoagulant system, is an important vitamin K-dependent protein that regulates the physiological coagulation cascade by inactivating factors Va and VIIIa upon activation by thrombin <xref rid="pone.0035773-Esmon1" ref-type="bibr">[1]</xref>â<xref rid="pone.0035773-Marlar1" ref-type="bibr">[3]</xref>. The mature PC molecule is a single- chain, 62-kDa glycoprotein that is synthesized by hepatocytes as a 461-amino acid precursor from which a 42-amino acid signal peptide is cleaved. Protein C is composed of a Î³-carboxy-glutamic acid residue (Gla) domain, two epidermal growth factor (EGF)-like domains, a short activation peptide, and a serine protease domain <xref rid="pone.0035773-Fisher1" ref-type="bibr">[4]</xref>, <xref rid="pone.0035773-Perera1" ref-type="bibr">[5]</xref>. Thrombin cleaves PC at Arg169, removes the activation peptide and generates activated protein C (APC) <xref rid="pone.0035773-Kisiel1" ref-type="bibr">[6]</xref>. In addition to its anticoagulant properties, APC has anti-inflammatory and cytoprotective functions, which are exerted when APC activating protease activated receptor-1 (PAR-1) <xref rid="pone.0035773-Dahlbck2" ref-type="bibr">[7]</xref>, <xref rid="pone.0035773-Mosnier1" ref-type="bibr">[8]</xref>. The human protein C gene (<italic>PROC</italic>) is located on chromosome 2q13-q14 and comprises nine exons spanning 11 kb <xref rid="pone.0035773-Foster1" ref-type="bibr">[9]</xref>, <xref rid="pone.0035773-Plutzky1" ref-type="bibr">[10]</xref>.</p>
      <p>The most common genetic risk factors for venous thrombosis in Whites, factor V Leiden (FV R506Q) and prothrombin G20210A polymorphism, are rare in Eastern populations <xref rid="pone.0035773-Bertina1" ref-type="bibr">[11]</xref>â<xref rid="pone.0035773-Bounameaux1" ref-type="bibr">[13]</xref>. Therefore, the three main physiological anticoagulant (antithrombin, protein C, and protein S) deficiencies are important risk factors in Asians, and their diagnosis is of great clinical interest <xref rid="pone.0035773-Roberts1" ref-type="bibr">[14]</xref>, <xref rid="pone.0035773-Suehisa1" ref-type="bibr">[15]</xref>. Hereditary protein C deficiency (OMIM#176860) is usually inherited as an autosomal dominant trait and is associated with an increased risk of venous thrombosis and hereditary thrombophilia. Heterozygous individuals have an approximately 7-fold increased risk of venous thrombosis compared with normal individuals <xref rid="pone.0035773-Koster1" ref-type="bibr">[16]</xref>. The homozygous (or compound heterozygous) state of protein C deficiency is much more rare <xref rid="pone.0035773-Millar1" ref-type="bibr">[17]</xref>. The overlap in the plasma protein C levels between healthy individuals and PC heterozygotes makes the discrimination between these two groups solely based on a single plasma measurement challenging <xref rid="pone.0035773-Allaart1" ref-type="bibr">[18]</xref>. Genetic determination is likely to be more powerful.</p>
      <p>To date, a number of mutations in the <italic>PROC</italic> gene associated with PC deficiency have been identified, but only a few of these variants were observed in the Chinese population, and the genetic characteristics of PC deficiency in Chinese patients have not been studied. Here, we report the results of the genetic investigation of protein C deficiency in 34 Chinese families and present a prevalent causative variant for PC deficiency and venous thrombosis.</p>
    </sec>
    <sec sec-type="methods" id="s2">
      <title>Methods</title>
      <sec id="s2a">
        <title>Ethics Statement</title>
        <p>This study was approved by the ethics committee of Union Hospital, Huazhong University of Science and Technology and complied with the principles expressed in the Declaration of Helsinki. Written informed consent was obtained from all participants.</p>
      </sec>
      <sec id="s2b">
        <title>Protein C-deficient patients and sample collection</title>
        <p>A total of 34 unrelated probands diagnosed with hereditary protein C deficiency and registered at the Hubei Clinical and Research Center of Thrombosis and Hemostasis from 2008 to 2010 were investigated. The diagnosis was based on repeated low plasma protein C activity measurements and a personal or family history of symptomatic thromboembolic diseases.</p>
        <p>Blood samples were collected from all subjects during a non-acute phase of VT (at least one month after a VT incident), and the patients had not received anticoagulant therapy for at least two weeks before the collection. The blood sample was collected by venipuncture into a vacutainer tube containing 1/10 volume of 0.105 mol/L trisodium citrate and was immediately centrifuged at 2000Ã <italic>g</italic> for 15 min. The platelet-poor plasma was stored at â80Â°C until assayed. High molecular weight genomic DNA was isolated from white blood cells and standardized to 50 ng/Âµl.</p>
      </sec>
      <sec id="s2c">
        <title>Coagulation assays</title>
        <p>Protein C, protein S, and antithrombin activities were assayed on a Sysmex CA 7000 Analyzer (Sysmex, Japan) using commercial reagents obtained from Dade Behring-Siemens Healthcare Diagnostics, Germany. Protein C and antithrombin activities were measured using a chromogenic substrate method. The APC-cofactor activity of protein S was evaluated using a clotting method. Protein C antigen was further tested by an enzyme-linked immunosorbent assay using ZYMUTEST Protein C (Hyphen BioMed, France). The normal ranges of these tests in our lab were established in 78 healthy subjects.</p>
      </sec>
      <sec id="s2d">
        <title>The <italic>PROC</italic> gene analysis</title>
        <p>The <italic>PROC</italic> gene was analyzed in each proband by PCR and resequencing. All nine exons, including at least 100 bp flanking intron regions, and the 5â²- and 3â²-untranslated regions of the human protein C gene were amplified. Detailed amplification conditions and the sequences of the oligonucleotide primers used are available upon request. The amplified fragments were sequenced on an ABI PRISM 3730XL automated sequencer (Applied Biosystems). Identified variants were confirmed on a second PCR product, sequencing on both strands. The variants were designated according to current nomenclature and the recommendations of the Human Genome Variation Society (HGVS, <ext-link ext-link-type="uri" xlink:href="http://www.hgvs.org/mutnomen/">http://www.hgvs.org/mutnomen/</ext-link>) and were checked using the Mutalyzer program <xref rid="pone.0035773-denDunnen1" ref-type="bibr">[19]</xref>â<xref rid="pone.0035773-Wildeman1" ref-type="bibr">[21]</xref>. All new data have been deposited in GenBank under accession numbers NM_000312.3 and NP_000303.1. Each novel variant was then detected in 50 normal individuals (100 alleles) using direct sequencing.</p>
      </sec>
      <sec id="s2e">
        <title>
<italic>In silico</italic> analysis of novel amino acid changes</title>
        <p>The possible impact of novel coding sequence changes (amino acid substitutions) on the structure and function of PC was assessed using two bioinformatics tools, Sorting Intolerant From Tolerant (SIFT, <ext-link ext-link-type="uri" xlink:href="http://sift.jcvi.org">http://sift.jcvi.org</ext-link>) and Polymorphism Phenotyping-2 (PolyPhen-2, <ext-link ext-link-type="uri" xlink:href="http://genetics.bwh.harvard.edu/pph2/">http://genetics.bwh.harvard.edu/pph2/</ext-link>) <xref rid="pone.0035773-Kumar1" ref-type="bibr">[22]</xref>, <xref rid="pone.0035773-Adzhubei1" ref-type="bibr">[23]</xref>. The UniProtKB Protein ID âP04070â and Protein Ensembl ENSP ID âENSP00000234071â were used, respectively.</p>
        <p>The conservation of the affected amino acids were further checked by multiple sequence alignment (HomoloGene, <ext-link ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/sites/entrez">http://www.ncbi.nlm.nih.gov/sites/entrez</ext-link>) with sequences from <italic>Pantroglodytes</italic>, <italic>Canis lupus familiaris</italic>, <italic>Bos taurus</italic>, <italic>Mus musculus</italic>, <italic>Rattus norvegicus</italic>, and <italic>Gallus gallus</italic>.</p>
      </sec>
      <sec id="s2f">
        <title>Splicing efficiency prediction</title>
        <p>The effect of exon-intron boundary variants on the efficiency of splice processing was predicted by two web server programs: SplicePort (<ext-link ext-link-type="uri" xlink:href="http://spliceport.cs.umd.edu/">http://spliceport.cs.umd.edu/</ext-link>) and Alternative Splice Site Predictor (ASSP, <ext-link ext-link-type="uri" xlink:href="http://www.es.embnet.org/~mwang/assp.html">http://www.es.embnet.org/~mwang/assp.html</ext-link>) <xref rid="pone.0035773-Wang1" ref-type="bibr">[24]</xref>, <xref rid="pone.0035773-Dogan1" ref-type="bibr">[25]</xref>.</p>
      </sec>
      <sec id="s2g">
        <title>Protein molecular modeling</title>
        <p>The molecular structures of the wild-type and mutant proteins were modeled using Swiss model workspace (<ext-link ext-link-type="uri" xlink:href="http://swissmodel.expasy.org/">http://swissmodel.expasy.org/</ext-link>) <xref rid="pone.0035773-Kiefer1" ref-type="bibr">[26]</xref> and noc-3.01 software based on the tridimensional crystal structure of PC (PDB ID: 3F6U) <xref rid="pone.0035773-Schmidt1" ref-type="bibr">[27]</xref>.</p>
      </sec>
      <sec id="s2h">
        <title>Recurrent mutation detection in venous thrombosis patients and controls</title>
        <p>The <italic>PROC</italic> c.565C&gt;T mutation, which was common among the probands, was subsequently detected in an independent case-control study to evaluate the OR of this variant for venous thrombosis in the Chinese population.</p>
        <p>This secondary study included consecutive unrelated patients (nâ=â1003) who were diagnosed with venous thrombosis at the Hubei Clinical and Research Center of Thrombosis and Hemostasis from 2008 to 2011. The thrombosis incidents were validated based on clinical manifestations, D-dimer levels, Doppler ultrasound (for deep vein thrombosis), ventilation perfusion lung scan, and/or computed tomography angiography (for pulmonary embolism). Age- and sex-matched controls (nâ=â1031) without an individual or family history of VT were enrolled from a community screening program in the same regions during the same time window. Demographic data and acquired thrombotic risk factors were recorded. Blood samples were collected from all participants.</p>
        <p>All of the participants included in the case-control study were central Chinese. To test whether this PC variant was also common in populations from other regions of China, we recruited a cohort of 492 healthy individuals (43.9% female) who were evaluated for routine physical check-up in Shanghai (Dongfang Hospital, eastern China) in February 2012. The healthy Shanghai participants ranged in age from 38 to 66 years and had no family history of thrombosis. Blood samples were collected, and genomic DNA was extracted and prepared for genotyping.</p>
        <p>The c.565C&gt;T mutation was genotyped using the PCR-RFLP method. The mutagenic primers <named-content content-type="gene">5â²-TCCTTGAACCCTGCACTGTGGCAA-3â²</named-content> and <named-content content-type="gene">5â²-TTTCAGGTGACT<italic><underline>A</underline></italic>CGC- TTCTTCTCCAT<italic><underline>G</underline></italic>C-3â²</named-content> were employed. The underlined and italicized base G in the lower primer was used to introduce a Hin6 I restriction site into the normal allele. In contrast, the underlined and italicized base A was used to eliminate an adjacent restriction site. Therefore, only the PCR product of the common allele has a Hin6 I recognition site. Altogether, 10 Âµl of PCR product was digested with 5 U of Hin6 I (Fermentas, Canada) for 3 hours at 37Â°C and then subjected to 2% agarose gel electrophoresis. To verify the genotyping results determined by PCR/RFLP assay, up to 192 DNA samples were randomly selected and subjected to sequencing.</p>
      </sec>
      <sec id="s2i">
        <title>Family analysis of the recurrent mutation</title>
        <p>To avoid bias, probands were excluded, and analyses were performed on first-degree relatives only. Included families were composed of at least two family members (one c.565C&gt;T carrier and one non-carrier). Six families were excluded because they did not meet the criteria. In total, 49 family members from 11 families were enrolled to estimate the thrombotic risk associated with the recurrent mutation. The annual incidence of thrombosis was calculated by dividing the number of events in each group (carriers and non-carriers) by the total number of patient-years of follow-up. For each individual, years of follow-up were defined as the time from the date of birth to either the date of the first episode of venous thrombosis, if any, or December 2011. The relative risks were calculated using only the first thrombotic event during follow-up.</p>
      </sec>
      <sec id="s2j">
        <title>Statistical analysis</title>
        <p>For continuous variables, differences between groups were analyzed by a Student's <italic>t</italic>-test or Mann-Whitney U-test, depending on the normality of the data. A chi-squared test was used for categorical variables. Deviations from Hardy-Weinberg expectations were assessed using both Fisher's Exact test and chi-squared test. Multivariate logistic regression analysis was used to calculate the OR of the c.565C&gt;T mutation for venous thrombosis adjusted for selected confounders (age, gender, smoking status, alcohol abuse, malignant tumor, type 2 diabetes, sedentariness/immobilization, and pregnancy/puerperium). A Cox regression analysis was performed to estimate the relative risk (hazard ratio) for thrombosis in first-degree relatives with the c.565C&gt;T mutation, adjusted for age and gender. Statistical power was estimated using the Power and Sample (PS) size calculation program <xref rid="pone.0035773-Dupont1" ref-type="bibr">[28]</xref>. A two-tailed <italic>P</italic>&lt;0.05 was considered statistically significant. Analyses were performed using SPSS version 12.0 software (SPSS Inc., Chicago, IL).</p>
      </sec>
    </sec>
    <sec id="s3">
      <title>Results</title>
      <sec id="s3a">
        <title>Mutation profiles</title>
        <p>Eighteen different genetic variants (12 novel) were identified in 32 of the 34 probands (94.1%). No candidate mutations were found in the other two subjects, most likely due to gross insertion/deletion of the <italic>PROC</italic> gene. The mutation profiles consisted of 14 missense mutations, two splice site mutations, one small deletion, one small duplication, and one 3â²-untranslated region variant. Each novel variant identified in a proband was shown to cosegregate with a low plasma PC level in the family. All of the novel variants were absent in all 50 healthy individuals, suggesting that they are not common polymorphisms. The mutation profiles are summarized in <xref ref-type="table" rid="pone-0035773-t001">Table 1</xref>.</p>
        <table-wrap id="pone-0035773-t001" position="float">
          <object-id pub-id-type="doi">10.1371/journal.pone.0035773.t001</object-id>
          <label>Table 1</label>
          <caption>
            <title>Mutation profiles, laboratory, and clinical data of for patients with PC deficiency.</title>
          </caption>
          <alternatives>
            <graphic id="pone-0035773-t001-1" xlink:href="pone.0035773.t001"/>
            <table frame="hsides" rules="groups">
              <colgroup span="1">
                <col align="left" span="1"/>
                <col align="center" span="1"/>
                <col align="center" span="1"/>
                <col align="center" span="1"/>
                <col align="center" span="1"/>
                <col align="center" span="1"/>
                <col align="center" span="1"/>
                <col align="center" span="1"/>
              </colgroup>
              <thead>
                <tr>
                  <td align="left" rowspan="1" colspan="1">Patient No.</td>
                  <td align="left" rowspan="1" colspan="1">Age</td>
                  <td align="left" rowspan="1" colspan="1">Clinical data</td>
                  <td align="left" rowspan="1" colspan="1">PCâ¶A (U/dl)</td>
                  <td align="left" rowspan="1" colspan="1">PCâ¶Ag (U/dl)</td>
                  <td align="left" rowspan="1" colspan="1">NT exchange</td>
                  <td align="left" rowspan="1" colspan="1">AA substitution</td>
                  <td align="left" rowspan="1" colspan="1">Ref.</td>
                </tr>
              </thead>
              <tbody>
                <tr>
                  <td align="left" rowspan="1" colspan="1">PC1</td>
                  <td align="left" rowspan="1" colspan="1">15</td>
                  <td align="left" rowspan="1" colspan="1">DVT</td>
                  <td align="left" rowspan="1" colspan="1">6.3</td>
                  <td align="left" rowspan="1" colspan="1">12.6</td>
                  <td align="left" rowspan="1" colspan="1">c.889G&gt;C c.1258G&gt;T</td>
                  <td align="left" rowspan="1" colspan="1">p.Asp297His p.Val420Leu</td>
                  <td align="left" rowspan="1" colspan="1">novel novel</td>
                </tr>
                <tr>
                  <td align="left" rowspan="1" colspan="1">PC3</td>
                  <td align="left" rowspan="1" colspan="1">64</td>
                  <td align="left" rowspan="1" colspan="1">DVT</td>
                  <td align="left" rowspan="1" colspan="1">40.4</td>
                  <td align="left" rowspan="1" colspan="1">48.3</td>
                  <td align="left" rowspan="1" colspan="1">c.*73C&gt;T</td>
                  <td align="left" rowspan="1" colspan="1">-</td>
                  <td align="left" rowspan="1" colspan="1">novel</td>
                </tr>
                <tr>
                  <td align="left" rowspan="1" colspan="1">PC4</td>
                  <td align="left" rowspan="1" colspan="1">33</td>
                  <td align="left" rowspan="1" colspan="1">DVT</td>
                  <td align="left" rowspan="1" colspan="1">52.9</td>
                  <td align="left" rowspan="1" colspan="1">58.8</td>
                  <td align="left" rowspan="1" colspan="1">c.524G&gt;A</td>
                  <td align="left" rowspan="1" colspan="1">p.Cys175Tyr</td>
                  <td align="left" rowspan="1" colspan="1">novel</td>
                </tr>
                <tr>
                  <td align="left" rowspan="1" colspan="1">PC6</td>
                  <td align="left" rowspan="1" colspan="1">32</td>
                  <td align="left" rowspan="1" colspan="1">DVT/MVT</td>
                  <td align="left" rowspan="1" colspan="1">36.4</td>
                  <td align="left" rowspan="1" colspan="1">49.2</td>
                  <td align="left" rowspan="1" colspan="1">c.716dupG</td>
                  <td align="left" rowspan="1" colspan="1">p.Ala240GlyfsX17</td>
                  <td align="left" rowspan="1" colspan="1">novel</td>
                </tr>
                <tr>
                  <td align="left" rowspan="1" colspan="1">PC7</td>
                  <td align="left" rowspan="1" colspan="1">55</td>
                  <td align="left" rowspan="1" colspan="1">DVT</td>
                  <td align="left" rowspan="1" colspan="1">52.1</td>
                  <td align="left" rowspan="1" colspan="1">31.5</td>
                  <td align="left" rowspan="1" colspan="1">c.632G&gt;A</td>
                  <td align="left" rowspan="1" colspan="1">p.Arg211Gln</td>
                  <td align="left" rowspan="1" colspan="1">
<xref rid="pone.0035773-Poort2" ref-type="bibr">[32]</xref>
</td>
                </tr>
                <tr>
                  <td align="left" rowspan="1" colspan="1">PC11</td>
                  <td align="left" rowspan="1" colspan="1">24</td>
                  <td align="left" rowspan="1" colspan="1">DVT/PE</td>
                  <td align="left" rowspan="1" colspan="1">9.9</td>
                  <td align="left" rowspan="1" colspan="1">9.2</td>
                  <td align="left" rowspan="1" colspan="1">c.349_352del c.541T&gt;G</td>
                  <td align="left" rowspan="1" colspan="1">p.Phe118AlafsX16 p.Phe181Val</td>
                  <td align="left" rowspan="1" colspan="1">Novel <xref rid="pone.0035773-Miyata1" ref-type="bibr">[33]</xref>
</td>
                </tr>
                <tr>
                  <td align="left" rowspan="1" colspan="1">PC12</td>
                  <td align="left" rowspan="1" colspan="1">45</td>
                  <td align="left" rowspan="1" colspan="1">DVT</td>
                  <td align="left" rowspan="1" colspan="1">61.7</td>
                  <td align="left" rowspan="1" colspan="1">53.4</td>
                  <td align="left" rowspan="1" colspan="1">c.400+5G&gt;A</td>
                  <td align="left" rowspan="1" colspan="1">-</td>
                  <td align="left" rowspan="1" colspan="1">
<xref rid="pone.0035773-Reitsma1" ref-type="bibr">[29]</xref>
</td>
                </tr>
                <tr>
                  <td align="left" rowspan="1" colspan="1">PC15</td>
                  <td align="left" rowspan="1" colspan="1">65</td>
                  <td align="left" rowspan="1" colspan="1">DVT</td>
                  <td align="left" rowspan="1" colspan="1">49.3</td>
                  <td align="left" rowspan="1" colspan="1">61.7</td>
                  <td align="left" rowspan="1" colspan="1">not found</td>
                  <td align="left" rowspan="1" colspan="1">-</td>
                  <td align="left" rowspan="1" colspan="1">-</td>
                </tr>
                <tr>
                  <td align="left" rowspan="1" colspan="1">PC16</td>
                  <td align="left" rowspan="1" colspan="1">46</td>
                  <td align="left" rowspan="1" colspan="1">DVT</td>
                  <td align="left" rowspan="1" colspan="1">44.1</td>
                  <td align="left" rowspan="1" colspan="1">53.3</td>
                  <td align="left" rowspan="1" colspan="1">c.316T&gt;G</td>
                  <td align="left" rowspan="1" colspan="1">p.Cys106Gly</td>
                  <td align="left" rowspan="1" colspan="1">novel</td>
                </tr>
                <tr>
                  <td align="left" rowspan="1" colspan="1">PC17</td>
                  <td align="left" rowspan="1" colspan="1">46</td>
                  <td align="left" rowspan="1" colspan="1">DVT/PE</td>
                  <td align="left" rowspan="1" colspan="1">57.7</td>
                  <td align="left" rowspan="1" colspan="1">65.2</td>
                  <td align="left" rowspan="1" colspan="1">c.889G&gt;C c.891C&gt;T</td>
                  <td align="left" rowspan="1" colspan="1">p.Asp297His</td>
                  <td align="left" rowspan="1" colspan="1">novel novel</td>
                </tr>
                <tr>
                  <td align="left" rowspan="1" colspan="1">PC19</td>
                  <td align="left" rowspan="1" colspan="1">44</td>
                  <td align="left" rowspan="1" colspan="1">DVT</td>
                  <td align="left" rowspan="1" colspan="1">30.4</td>
                  <td align="left" rowspan="1" colspan="1">76.7</td>
                  <td align="left" rowspan="1" colspan="1">c.935C&gt;T</td>
                  <td align="left" rowspan="1" colspan="1">p.Ser312Leu</td>
                  <td align="left" rowspan="1" colspan="1">
<xref rid="pone.0035773-Reitsma2" ref-type="bibr">[34]</xref>
</td>
                </tr>
                <tr>
                  <td align="left" rowspan="1" colspan="1">PC20</td>
                  <td align="left" rowspan="1" colspan="1">37</td>
                  <td align="left" rowspan="1" colspan="1">DVT</td>
                  <td align="left" rowspan="1" colspan="1">40.9</td>
                  <td align="left" rowspan="1" colspan="1">38.3</td>
                  <td align="left" rowspan="1" colspan="1">c.658C&gt;T</td>
                  <td align="left" rowspan="1" colspan="1">p.Arg220Trp</td>
                  <td align="left" rowspan="1" colspan="1">
<xref rid="pone.0035773-Reitsma1" ref-type="bibr">[29]</xref>
</td>
                </tr>
                <tr>
                  <td align="left" rowspan="1" colspan="1">PC22</td>
                  <td align="left" rowspan="1" colspan="1">49</td>
                  <td align="left" rowspan="1" colspan="1">DVT</td>
                  <td align="left" rowspan="1" colspan="1">48.5</td>
                  <td align="left" rowspan="1" colspan="1">53.3</td>
                  <td align="left" rowspan="1" colspan="1">not found</td>
                  <td align="left" rowspan="1" colspan="1">-</td>
                  <td align="left" rowspan="1" colspan="1">-</td>
                </tr>
                <tr>
                  <td align="left" rowspan="1" colspan="1">PC25</td>
                  <td align="left" rowspan="1" colspan="1">42</td>
                  <td align="left" rowspan="1" colspan="1">DVT/AIS</td>
                  <td align="left" rowspan="1" colspan="1">39.4</td>
                  <td align="left" rowspan="1" colspan="1">26.7</td>
                  <td align="left" rowspan="1" colspan="1">c.541T&gt;G c.980A&gt;T</td>
                  <td align="left" rowspan="1" colspan="1">p.Phe181Val p.Glu327Val</td>
                  <td align="left" rowspan="1" colspan="1">
<xref rid="pone.0035773-Miyata1" ref-type="bibr">[33]</xref> novel</td>
                </tr>
                <tr>
                  <td align="left" rowspan="1" colspan="1">PC27</td>
                  <td align="left" rowspan="1" colspan="1">46</td>
                  <td align="left" rowspan="1" colspan="1">DVT</td>
                  <td align="left" rowspan="1" colspan="1">48.7</td>
                  <td align="left" rowspan="1" colspan="1">42.4</td>
                  <td align="left" rowspan="1" colspan="1">c.208A&gt;G</td>
                  <td align="left" rowspan="1" colspan="1">p.Lys70Glu</td>
                  <td align="left" rowspan="1" colspan="1">novel</td>
                </tr>
                <tr>
                  <td align="left" rowspan="1" colspan="1">PC28</td>
                  <td align="left" rowspan="1" colspan="1">54</td>
                  <td align="left" rowspan="1" colspan="1">DVT</td>
                  <td align="left" rowspan="1" colspan="1">40.0</td>
                  <td align="left" rowspan="1" colspan="1">53.0</td>
                  <td align="left" rowspan="1" colspan="1">c.237+5G&gt;A</td>
                  <td align="left" rowspan="1" colspan="1">-</td>
                  <td align="left" rowspan="1" colspan="1">novel</td>
                </tr>
                <tr>
                  <td align="left" rowspan="1" colspan="1">PC29</td>
                  <td align="left" rowspan="1" colspan="1">48</td>
                  <td align="left" rowspan="1" colspan="1">DVT</td>
                  <td align="left" rowspan="1" colspan="1">60.0</td>
                  <td align="left" rowspan="1" colspan="1">88.1</td>
                  <td align="left" rowspan="1" colspan="1">c.669C&gt;A</td>
                  <td align="left" rowspan="1" colspan="1">p.Ser223Arg</td>
                  <td align="left" rowspan="1" colspan="1">novel</td>
                </tr>
                <tr>
                  <td align="left" rowspan="1" colspan="1">PC31</td>
                  <td align="left" rowspan="1" colspan="1">64</td>
                  <td align="left" rowspan="1" colspan="1">DVT</td>
                  <td align="left" rowspan="1" colspan="1">44.2</td>
                  <td align="left" rowspan="1" colspan="1">42.4</td>
                  <td align="left" rowspan="1" colspan="1">c.541T&gt;G</td>
                  <td align="left" rowspan="1" colspan="1">p.Phe181Val</td>
                  <td align="left" rowspan="1" colspan="1">
<xref rid="pone.0035773-Grundy1" ref-type="bibr">[31]</xref>
</td>
                </tr>
                <tr>
                  <td align="left" rowspan="1" colspan="1">others</td>
                  <td align="left" rowspan="1" colspan="1">38â67</td>
                  <td align="left" rowspan="1" colspan="1">DVT</td>
                  <td align="left" rowspan="1" colspan="1">40.4â62.3</td>
                  <td align="left" rowspan="1" colspan="1">68.7â83.0</td>
                  <td align="left" rowspan="1" colspan="1">c.565C&gt;T</td>
                  <td align="left" rowspan="1" colspan="1">p.Arg189Trp</td>
                  <td align="left" rowspan="1" colspan="1">
<xref rid="pone.0035773-Reitsma2" ref-type="bibr">[34]</xref>
</td>
                </tr>
              </tbody>
            </table>
          </alternatives>
          <table-wrap-foot>
            <fn id="nt101">
              <label/>
              <p>Mutations were designated according to the HGVS nomenclature for variants, comparing with the NCBI Reference Sequences NM_000312.3 and NP_000303.1. Patients with two nucleotide substitutions indicated compound heterozygotes. NTâ=ânucleotide. AAâ=âamino acid. Ref.â=âReferences. DVTâ=âdeep vein thrombosis. MVTâ=âmesenteric vein thrombosis. PEâ=âpulmonary embolism. AISâ=âacute ischemic stroke.</p>
            </fn>
          </table-wrap-foot>
        </table-wrap>
      </sec>
      <sec id="s3b">
        <title>Missense mutations</title>
        <p>A total of 14 missense mutations resulted in amino acid substitutions. Eight are reported for the first time here. A multiple sequence alignment among selected species showed that seven of the newly identified mutations led to substitutions of highly conserved amino acids (<xref ref-type="fig" rid="pone-0035773-g001">Figure 1</xref>). Although Lys70 (basic amino acid) is not conserved, Glu (acidic amino acid) is never present at this site in the evaluated species. Novel missense mutations of p.Cys175Tyr, p.Asp297His, and p.Val420Leu were predicted to be deleterious by both the SIFT and PolyPhen-2 algorithms. The other four mutations (p.Lys70Glu, p.Cys106Gly, p.Ser223Arg, and p.Glu327Val) were predicted to be damaging by one algorithm. The location of each affected amino acid and the correlative structure of mutant PC are depicted in <xref ref-type="fig" rid="pone-0035773-g002">Figure 2</xref>.</p>
        <fig id="pone-0035773-g001" position="float">
          <object-id pub-id-type="doi">10.1371/journal.pone.0035773.g001</object-id>
          <label>Figure 1</label>
          <caption>
            <title>Multiple sequence alignment highlighting the affected amino acids among selected species.</title>
            <p>The conservation degree of the affected amino acids was evaluated in sequences from <italic>Homo sapiens</italic> (NP_000303.1), <italic>Bos taurus</italic> (NP_001159984.1), <italic>Canis lupus familiaris</italic> (NP_001013871.1), <italic>Gallus gallus</italic> (NP_989772.1), <italic>Mus musculus</italic> (NP_032960.3), <italic>Pan troglodytes</italic> (XP_515775.3), and <italic>Rattus norvegicus</italic> (NP_036935.1).</p>
          </caption>
          <graphic xlink:href="pone.0035773.g001"/>
        </fig>
        <fig id="pone-0035773-g002" position="float">
          <object-id pub-id-type="doi">10.1371/journal.pone.0035773.g002</object-id>
          <label>Figure 2</label>
          <caption>
            <title>Structure models of the wild-type and mutant PC proteins.</title>
            <p>The amino acid number was designated according to the previous nomenclature described in the Human Gene Mutation Database. That is, the first 42 amino acids (signal peptide) is subtracted. The wild-type amino acids are shown in yellow and the mutants are shown in red. The D255H and the E285V mutations are also displayed in a solid surface model (G, H) in which the electrostatic potential is clearly indicated.</p>
          </caption>
          <graphic xlink:href="pone.0035773.g002"/>
        </fig>
      </sec>
      <sec id="s3c">
        <title>Null mutations</title>
        <p>Five of the detected variants were suspected to result either in the complete absence of the gene product or in the expression of a non-functional protein; these mutations were defined as null mutations, and four of them are novel. The frameshift mutations c.719dupG and c.349_352del might produce a premature termination codon and lead to the production of a truncated protein. The c.237+5G&gt;A mutation occurs in the donor splice site of intron C. This substitution changed the splice site scores to 0.000 from original scores of 7.137 and 0.180 assigned by the splicing efficiency prediction programs ASSP and SplicePort, respectively. The closest candidate splice site was 46 bp downstream from the normal splice site. No matter whether the cryptic splice site would be used, this should result in an abnormal translation product. The c.*73C&gt;T variant, 73 bp downstream from the stop codon, completely cosegregated in the PC3 family and was absent in 50 control subjects. This mutation might affect the stability of the PC mRNA.</p>
      </sec>
      <sec id="s3d">
        <title>Recurrent mutation detection in patients and controls</title>
        <p>Seventeen of the 34 probands (50%) carried the same mutation, c.565C&gt;T (p.Arg189Trp), in exon 7. The recurrent mutation was then evaluated in an independent case-control study by PCR/RFLP (<xref ref-type="fig" rid="pone-0035773-g003">Figure 3</xref>). The genotyping data from the RFLP assays were completely consistent with those obtained by sequencing. The demographic data and acquired thrombotic risk factors of all subjects are presented in <xref ref-type="table" rid="pone-0035773-t002">Table 2</xref>. The heterozygous c.565C&gt;T mutation was identified in 59 (5.88%) venous thrombosis patients and 9 (0.87%) controls. The homozygous genotype was absent in all subjects. As illustrated in <xref ref-type="table" rid="pone-0035773-t003">Table 3</xref>, the observed OR of this mutation was 6.91 (95%CIâ=â3.42â13.98; <italic>P</italic>â=â4.67Ã10<sup>â10</sup>). Multivariate logistical regression analysis revealed that the association between the variant and VT was still significant (ORâ=â7.34; 95%CIâ=â3.61â14.94; <italic>P</italic>â=â3.88Ã10<sup>â8</sup>) after adjustment for age, gender, smoking status, alcohol abuse, malignant tumor, type 2 diabetes, sedentariness/immobilization, and pregnancy/puerperium in the dominant model. Meanwhile, this mutation was also detected and confirmed in 4 of the 492 (0.81%) healthy participants from Shanghai, indicating that this mutation is not restricted to the central Chinese population and is likely to be prevalent in the general population.</p>
        <fig id="pone-0035773-g003" position="float">
          <object-id pub-id-type="doi">10.1371/journal.pone.0035773.g003</object-id>
          <label>Figure 3</label>
          <caption>
            <title>
<italic>PROC</italic> c.565C&gt;T variant detection by PCR-RFLP and direct sequencing.</title>
            <p>(A) Electrophoretic patterns following Hin6 I digestion. PCR products were 173 bp. Only amplicons with the wild-type sequences were digested, yielding two bands of 143 bp and 30 bp. The digestion products were separated by 2% agarose gel electrophoresis. M, DNA marker with 50-bp ladder. Lanes 1, 2, and 4â6, normal individuals. Lane 3, heterozygous individual for the variant. (B) Chromatograms obtained by sequencing. Left, wild-type; Right, heterozygote.</p>
          </caption>
          <graphic xlink:href="pone.0035773.g003"/>
        </fig>
        <table-wrap id="pone-0035773-t002" position="float">
          <object-id pub-id-type="doi">10.1371/journal.pone.0035773.t002</object-id>
          <label>Table 2</label>
          <caption>
            <title>Data from participants enrolled in the secondary case-control study.</title>
          </caption>
          <alternatives>
            <graphic id="pone-0035773-t002-2" xlink:href="pone.0035773.t002"/>
            <table frame="hsides" rules="groups">
              <colgroup span="1">
                <col align="left" span="1"/>
                <col align="center" span="1"/>
                <col align="center" span="1"/>
                <col align="center" span="1"/>
                <col align="center" span="1"/>
                <col align="center" span="1"/>
              </colgroup>
              <thead>
                <tr>
                  <td align="left" rowspan="1" colspan="1">Variable</td>
                  <td colspan="2" align="left" rowspan="1">Cases</td>
                  <td colspan="2" align="left" rowspan="1">Controls</td>
                  <td align="left" rowspan="1" colspan="1">
<italic>P</italic>
</td>
                </tr>
                <tr>
                  <td align="left" rowspan="1" colspan="1"/>
                  <td align="left" rowspan="1" colspan="1">No.</td>
                  <td align="left" rowspan="1" colspan="1">%</td>
                  <td align="left" rowspan="1" colspan="1">No.</td>
                  <td align="left" rowspan="1" colspan="1">%</td>
                  <td align="left" rowspan="1" colspan="1"/>
                </tr>
              </thead>
              <tbody>
                <tr>
                  <td align="left" rowspan="1" colspan="1">Age (years)</td>
                  <td align="left" rowspan="1" colspan="1">51.45Â±14.36</td>
                  <td align="left" rowspan="1" colspan="1"/>
                  <td align="left" rowspan="1" colspan="1">50.26Â±14.52</td>
                  <td align="left" rowspan="1" colspan="1"/>
                  <td align="left" rowspan="1" colspan="1">0.063</td>
                </tr>
                <tr>
                  <td align="left" rowspan="1" colspan="1">Sex</td>
                  <td align="left" rowspan="1" colspan="1"/>
                  <td align="left" rowspan="1" colspan="1"/>
                  <td align="left" rowspan="1" colspan="1"/>
                  <td align="left" rowspan="1" colspan="1"/>
                  <td align="left" rowspan="1" colspan="1">0.970</td>
                </tr>
                <tr>
                  <td align="left" rowspan="1" colspan="1">
<italic>Male</italic>
</td>
                  <td align="left" rowspan="1" colspan="1">532</td>
                  <td align="left" rowspan="1" colspan="1">53.04%</td>
                  <td align="left" rowspan="1" colspan="1">546</td>
                  <td align="left" rowspan="1" colspan="1">52.96%</td>
                  <td align="left" rowspan="1" colspan="1"/>
                </tr>
                <tr>
                  <td align="left" rowspan="1" colspan="1">
<italic>Female</italic>
</td>
                  <td align="left" rowspan="1" colspan="1">471</td>
                  <td align="left" rowspan="1" colspan="1">46.96%</td>
                  <td align="left" rowspan="1" colspan="1">485</td>
                  <td align="left" rowspan="1" colspan="1">47.04%</td>
                  <td align="left" rowspan="1" colspan="1"/>
                </tr>
                <tr>
                  <td align="left" rowspan="1" colspan="1">Smoking</td>
                  <td align="left" rowspan="1" colspan="1"/>
                  <td align="left" rowspan="1" colspan="1"/>
                  <td align="left" rowspan="1" colspan="1"/>
                  <td align="left" rowspan="1" colspan="1"/>
                  <td align="left" rowspan="1" colspan="1">0.009</td>
                </tr>
                <tr>
                  <td align="left" rowspan="1" colspan="1">
<italic>Yes</italic>
</td>
                  <td align="left" rowspan="1" colspan="1">227</td>
                  <td align="left" rowspan="1" colspan="1">22.6%</td>
                  <td align="left" rowspan="1" colspan="1">185</td>
                  <td align="left" rowspan="1" colspan="1">17.9%</td>
                  <td align="left" rowspan="1" colspan="1"/>
                </tr>
                <tr>
                  <td align="left" rowspan="1" colspan="1">
<italic>No</italic>
</td>
                  <td align="left" rowspan="1" colspan="1">776</td>
                  <td align="left" rowspan="1" colspan="1">77.4%</td>
                  <td align="left" rowspan="1" colspan="1">846</td>
                  <td align="left" rowspan="1" colspan="1">82.1%</td>
                  <td align="left" rowspan="1" colspan="1"/>
                </tr>
                <tr>
                  <td align="left" rowspan="1" colspan="1">Alcohol drinker</td>
                  <td align="left" rowspan="1" colspan="1"/>
                  <td align="left" rowspan="1" colspan="1"/>
                  <td align="left" rowspan="1" colspan="1"/>
                  <td align="left" rowspan="1" colspan="1"/>
                  <td align="left" rowspan="1" colspan="1">0.717</td>
                </tr>
                <tr>
                  <td align="left" rowspan="1" colspan="1">
<italic>Yes</italic>
</td>
                  <td align="left" rowspan="1" colspan="1">117</td>
                  <td align="left" rowspan="1" colspan="1">11.7%</td>
                  <td align="left" rowspan="1" colspan="1">115</td>
                  <td align="left" rowspan="1" colspan="1">11.2%</td>
                  <td align="left" rowspan="1" colspan="1"/>
                </tr>
                <tr>
                  <td align="left" rowspan="1" colspan="1">
<italic>No</italic>
</td>
                  <td align="left" rowspan="1" colspan="1">886</td>
                  <td align="left" rowspan="1" colspan="1">88.3%</td>
                  <td align="left" rowspan="1" colspan="1">916</td>
                  <td align="left" rowspan="1" colspan="1">88.8%</td>
                  <td align="left" rowspan="1" colspan="1"/>
                </tr>
                <tr>
                  <td align="left" rowspan="1" colspan="1">Malignant tumor</td>
                  <td align="left" rowspan="1" colspan="1"/>
                  <td align="left" rowspan="1" colspan="1"/>
                  <td align="left" rowspan="1" colspan="1"/>
                  <td align="left" rowspan="1" colspan="1"/>
                  <td align="left" rowspan="1" colspan="1">1.207Ã10<sup>â13</sup>
</td>
                </tr>
                <tr>
                  <td align="left" rowspan="1" colspan="1">
<italic>Yes</italic>
</td>
                  <td align="left" rowspan="1" colspan="1">65</td>
                  <td align="left" rowspan="1" colspan="1">6.5%</td>
                  <td align="left" rowspan="1" colspan="1">5</td>
                  <td align="left" rowspan="1" colspan="1">0.5%</td>
                  <td align="left" rowspan="1" colspan="1"/>
                </tr>
                <tr>
                  <td align="left" rowspan="1" colspan="1">
<italic>No</italic>
</td>
                  <td align="left" rowspan="1" colspan="1">938</td>
                  <td align="left" rowspan="1" colspan="1">93.5%</td>
                  <td align="left" rowspan="1" colspan="1">1026</td>
                  <td align="left" rowspan="1" colspan="1">99.5%</td>
                  <td align="left" rowspan="1" colspan="1"/>
                </tr>
                <tr>
                  <td align="left" rowspan="1" colspan="1">T2DM</td>
                  <td align="left" rowspan="1" colspan="1"/>
                  <td align="left" rowspan="1" colspan="1"/>
                  <td align="left" rowspan="1" colspan="1"/>
                  <td align="left" rowspan="1" colspan="1"/>
                  <td align="left" rowspan="1" colspan="1">0.037</td>
                </tr>
                <tr>
                  <td align="left" rowspan="1" colspan="1">
<italic>Yes</italic>
</td>
                  <td align="left" rowspan="1" colspan="1">42</td>
                  <td align="left" rowspan="1" colspan="1">4.2%</td>
                  <td align="left" rowspan="1" colspan="1">26</td>
                  <td align="left" rowspan="1" colspan="1">2.5%</td>
                  <td align="left" rowspan="1" colspan="1"/>
                </tr>
                <tr>
                  <td align="left" rowspan="1" colspan="1">
<italic>No</italic>
</td>
                  <td align="left" rowspan="1" colspan="1">961</td>
                  <td align="left" rowspan="1" colspan="1">95.8%</td>
                  <td align="left" rowspan="1" colspan="1">1005</td>
                  <td align="left" rowspan="1" colspan="1">97.5%</td>
                  <td align="left" rowspan="1" colspan="1"/>
                </tr>
                <tr>
                  <td align="left" rowspan="1" colspan="1">Sedentariness</td>
                  <td align="left" rowspan="1" colspan="1"/>
                  <td align="left" rowspan="1" colspan="1"/>
                  <td align="left" rowspan="1" colspan="1"/>
                  <td align="left" rowspan="1" colspan="1"/>
                  <td align="left" rowspan="1" colspan="1">0.031</td>
                </tr>
                <tr>
                  <td align="left" rowspan="1" colspan="1">
<italic>Yes</italic>
</td>
                  <td align="left" rowspan="1" colspan="1">23</td>
                  <td align="left" rowspan="1" colspan="1">2.3%</td>
                  <td align="left" rowspan="1" colspan="1">11</td>
                  <td align="left" rowspan="1" colspan="1">1.1<bold>%</bold>
</td>
                  <td align="left" rowspan="1" colspan="1"/>
                </tr>
                <tr>
                  <td align="left" rowspan="1" colspan="1">
<italic>No</italic>
</td>
                  <td align="left" rowspan="1" colspan="1">980</td>
                  <td align="left" rowspan="1" colspan="1">97.7%</td>
                  <td align="left" rowspan="1" colspan="1">1020</td>
                  <td align="left" rowspan="1" colspan="1">98.9<bold>%</bold>
</td>
                  <td align="left" rowspan="1" colspan="1"/>
                </tr>
                <tr>
                  <td align="left" rowspan="1" colspan="1">Pregnancy/puerperium</td>
                  <td align="left" rowspan="1" colspan="1"/>
                  <td align="left" rowspan="1" colspan="1"/>
                  <td align="left" rowspan="1" colspan="1"/>
                  <td align="left" rowspan="1" colspan="1"/>
                  <td align="left" rowspan="1" colspan="1"/>
                </tr>
                <tr>
                  <td align="left" rowspan="1" colspan="1">
<italic>Yes</italic>
</td>
                  <td align="left" rowspan="1" colspan="1">26</td>
                  <td align="left" rowspan="1" colspan="1">2.6%</td>
                  <td align="left" rowspan="1" colspan="1">14</td>
                  <td align="left" rowspan="1" colspan="1">1.4%</td>
                  <td align="left" rowspan="1" colspan="1">0.045</td>
                </tr>
                <tr>
                  <td align="left" rowspan="1" colspan="1">
<italic>No</italic>
</td>
                  <td align="left" rowspan="1" colspan="1">977</td>
                  <td align="left" rowspan="1" colspan="1">97.4%</td>
                  <td align="left" rowspan="1" colspan="1">1017</td>
                  <td align="left" rowspan="1" colspan="1">98.6%</td>
                  <td align="left" rowspan="1" colspan="1"/>
                </tr>
              </tbody>
            </table>
          </alternatives>
          <table-wrap-foot>
            <fn id="nt102">
              <label/>
              <p>Years of age were expressed as meanÂ±standard deviation. Age of cases: age at the first incident. Age of controls: age at enrollment. Age was further divided into three levels: under 40 years, 40 to 60 years, and over 60 years. Sedentariness/immobilization reflects the 4 weeks prior to the venous thrombosis incident. A Chi-squared test was used to compare the differences between groups according to gender, smoking status, alcohol abuse, malignant tumor, type 2 diabetes, sedentariness/immobilization, and pregnancy/puerperium. A Student's <italic>t</italic> test was used to compare the mean ages of the cases and controls. VTâ=âvenous thrombosis. T2DMâ=âtype 2 diabetes mellitus.</p>
            </fn>
          </table-wrap-foot>
        </table-wrap>
        <table-wrap id="pone-0035773-t003" position="float">
          <object-id pub-id-type="doi">10.1371/journal.pone.0035773.t003</object-id>
          <label>Table 3</label>
          <caption>
            <title>Association between the <italic>PROC</italic> c.565C&gt;T and venous thrombosis in the Chinese population.</title>
          </caption>
          <alternatives>
            <graphic id="pone-0035773-t003-3" xlink:href="pone.0035773.t003"/>
            <table frame="hsides" rules="groups">
              <colgroup span="1">
                <col align="left" span="1"/>
                <col align="center" span="1"/>
                <col align="center" span="1"/>
                <col align="center" span="1"/>
                <col align="center" span="1"/>
                <col align="center" span="1"/>
                <col align="center" span="1"/>
                <col align="center" span="1"/>
                <col align="center" span="1"/>
                <col align="center" span="1"/>
                <col align="center" span="1"/>
              </colgroup>
              <thead>
                <tr>
                  <td align="left" rowspan="1" colspan="1">
<italic>PROC</italic> c.565C&gt;T</td>
                  <td colspan="2" align="left" rowspan="1">Cases</td>
                  <td colspan="2" align="left" rowspan="1">Controls</td>
                  <td colspan="3" align="left" rowspan="1">Without adjustment</td>
                  <td colspan="3" align="left" rowspan="1">After adjustment<xref ref-type="table-fn" rid="nt104">*</xref>
</td>
                </tr>
                <tr>
                  <td align="left" rowspan="1" colspan="1"/>
                  <td align="left" rowspan="1" colspan="1">No.</td>
                  <td align="left" rowspan="1" colspan="1">%</td>
                  <td align="left" rowspan="1" colspan="1">No.</td>
                  <td align="left" rowspan="1" colspan="1">%</td>
                  <td align="left" rowspan="1" colspan="1">OR</td>
                  <td align="left" rowspan="1" colspan="1">95%CI</td>
                  <td align="left" rowspan="1" colspan="1">
<italic>P</italic>
</td>
                  <td align="left" rowspan="1" colspan="1">OR</td>
                  <td align="left" rowspan="1" colspan="1">95%CI</td>
                  <td align="left" rowspan="1" colspan="1">
<italic>P</italic>
</td>
                </tr>
              </thead>
              <tbody>
                <tr>
                  <td align="left" rowspan="1" colspan="1">C/C</td>
                  <td align="left" rowspan="1" colspan="1">944</td>
                  <td align="left" rowspan="1" colspan="1">94.12%</td>
                  <td align="left" rowspan="1" colspan="1">1022</td>
                  <td align="left" rowspan="1" colspan="1">99.13%</td>
                  <td align="left" rowspan="1" colspan="1">1</td>
                  <td align="left" rowspan="1" colspan="1">-</td>
                  <td align="left" rowspan="1" colspan="1">-</td>
                  <td align="left" rowspan="1" colspan="1">1</td>
                  <td align="left" rowspan="1" colspan="1">-</td>
                  <td align="left" rowspan="1" colspan="1">-</td>
                </tr>
                <tr>
                  <td align="left" rowspan="1" colspan="1">C/T</td>
                  <td align="left" rowspan="1" colspan="1">59</td>
                  <td align="left" rowspan="1" colspan="1">5.88%</td>
                  <td align="left" rowspan="1" colspan="1">9</td>
                  <td align="left" rowspan="1" colspan="1">0.87%</td>
                  <td align="left" rowspan="1" colspan="1">7.10</td>
                  <td align="left" rowspan="1" colspan="1">3.50â14.39</td>
                  <td align="left" rowspan="1" colspan="1">3.31Ã10<sup>â10</sup>
</td>
                  <td align="left" rowspan="1" colspan="1">7.34</td>
                  <td align="left" rowspan="1" colspan="1">3.61â14.94</td>
                  <td align="left" rowspan="1" colspan="1">3.88Ã10<sup>â8</sup>
</td>
                </tr>
                <tr>
                  <td align="left" rowspan="1" colspan="1">MAF</td>
                  <td align="left" rowspan="1" colspan="1">-</td>
                  <td align="left" rowspan="1" colspan="1">2.94%</td>
                  <td align="left" rowspan="1" colspan="1">-</td>
                  <td align="left" rowspan="1" colspan="1">0.44%</td>
                  <td align="left" rowspan="1" colspan="1">6.91</td>
                  <td align="left" rowspan="1" colspan="1">3.42â13.98</td>
                  <td align="left" rowspan="1" colspan="1">4.67Ã10<sup>â10</sup>
</td>
                  <td align="left" rowspan="1" colspan="1">-</td>
                  <td align="left" rowspan="1" colspan="1">-</td>
                  <td align="left" rowspan="1" colspan="1">-</td>
                </tr>
              </tbody>
            </table>
          </alternatives>
          <table-wrap-foot>
            <fn id="nt103">
              <label/>
              <p>Test for H-W equilibrium in controls: <italic>P</italic>â=â0.89. CIâ=âconfidence interval. MAFâ=âminor allele frequency.</p>
            </fn>
            <fn id="nt104">
              <label>*</label>
              <p>Data were analyzed by logistic regression adjusted for age, gender, smoking status, alcohol abuse, malignant tumor, type 2 diabetes, sedentariness/immobilization, and pregnancy/puerperium.</p>
            </fn>
          </table-wrap-foot>
        </table-wrap>
      </sec>
      <sec id="s3e">
        <title>Thrombotic risk in first-degree relatives with the c.565C&gt;T mutation</title>
        <p>As shown in <xref ref-type="table" rid="pone-0035773-t004">Table 4</xref>, the incidence of thrombosis was greater in first-degree relatives with the c.565C&gt;T mutation (7.9 per 1000 person-years) compared with those without this mutation (0.8 per 1000 person-years), with a relative risk of 8.8 (95%CIâ=â1.1â71.6) for thrombosis.</p>
        <table-wrap id="pone-0035773-t004" position="float">
          <object-id pub-id-type="doi">10.1371/journal.pone.0035773.t004</object-id>
          <label>Table 4</label>
          <caption>
            <title>Family analysis of thrombotic risk in c.565C&gt;T carriers and non-carriers.</title>
          </caption>
          <alternatives>
            <graphic id="pone-0035773-t004-4" xlink:href="pone.0035773.t004"/>
            <table frame="hsides" rules="groups">
              <colgroup span="1">
                <col align="left" span="1"/>
                <col align="center" span="1"/>
                <col align="center" span="1"/>
              </colgroup>
              <thead>
                <tr>
                  <td align="left" rowspan="1" colspan="1"/>
                  <td align="left" rowspan="1" colspan="1">Carriers</td>
                  <td align="left" rowspan="1" colspan="1">Non-carriers</td>
                </tr>
              </thead>
              <tbody>
                <tr>
                  <td align="left" rowspan="1" colspan="1">Number</td>
                  <td align="left" rowspan="1" colspan="1">20</td>
                  <td align="left" rowspan="1" colspan="1">29</td>
                </tr>
                <tr>
                  <td align="left" rowspan="1" colspan="1">Male/Female</td>
                  <td align="left" rowspan="1" colspan="1">12/8</td>
                  <td align="left" rowspan="1" colspan="1">16/13</td>
                </tr>
                <tr>
                  <td align="left" rowspan="1" colspan="1">Age at first thrombosis, median (range)</td>
                  <td align="left" rowspan="1" colspan="1">51.5 (49â61)</td>
                  <td align="left" rowspan="1" colspan="1">51</td>
                </tr>
                <tr>
                  <td align="left" rowspan="1" colspan="1">Years of follow up</td>
                  <td align="left" rowspan="1" colspan="1">890</td>
                  <td align="left" rowspan="1" colspan="1">1264</td>
                </tr>
                <tr>
                  <td align="left" rowspan="1" colspan="1">Number of VT events</td>
                  <td align="left" rowspan="1" colspan="1">7</td>
                  <td align="left" rowspan="1" colspan="1">1</td>
                </tr>
                <tr>
                  <td align="left" rowspan="1" colspan="1">Events per 1000 person-years (95%CI)</td>
                  <td align="left" rowspan="1" colspan="1">7.9 (7.6â8.1)</td>
                  <td align="left" rowspan="1" colspan="1">0.8</td>
                </tr>
                <tr>
                  <td align="left" rowspan="1" colspan="1">Relative risk for thrombosis (95% CI)<xref ref-type="table-fn" rid="nt105">*</xref>
</td>
                  <td align="left" rowspan="1" colspan="1">8.8 (1.1â71.6)</td>
                  <td align="left" rowspan="1" colspan="1">1</td>
                </tr>
              </tbody>
            </table>
          </alternatives>
          <table-wrap-foot>
            <fn id="nt105">
              <label>*</label>
              <p>Data were analyzed using a Cox regression model adjusted for age and gender.</p>
            </fn>
          </table-wrap-foot>
        </table-wrap>
      </sec>
    </sec>
    <sec id="s4">
      <title>Discussion</title>
      <p>Protein C deficiency is known to be associated with an increased risk of VT and its genetic background has been analyzed in several populations <xref rid="pone.0035773-Reitsma1" ref-type="bibr">[29]</xref>â<xref rid="pone.0035773-Grundy1" ref-type="bibr">[31]</xref>. In the present study, we systematically investigated the genetic characteristics of PC deficiency in the Chinese population.</p>
      <p>A total of 18 different mutations, including one recurrent mutation, were identified in 34 probands. Six of the detected variants (c.400+5G&gt;A, p.Phe181Val, p.Arg189Trp, p.Arg211Gln, p.Arg220Trp, and p.Ser312Leu) have been reported previously as disease-causing mutations <xref rid="pone.0035773-Reitsma1" ref-type="bibr">[29]</xref>, <xref rid="pone.0035773-Poort2" ref-type="bibr">[32]</xref>â<xref rid="pone.0035773-Reitsma2" ref-type="bibr">[34]</xref>.</p>
      <p>Eight novel coding sequence variants contributed to seven amino acid exchanges. The variant p.Lys70Glu is located in the Gla domain, which is involved in the interaction between PC and anionic phospholipid surfaces <xref rid="pone.0035773-Foster2" ref-type="bibr">[35]</xref>. This alteration creates a new Glu residue and changes the charge nature of this site, which might reduce the efficiency of the interaction with phospholipid membranes. The p.Cys106Gly and p.Cys175Tyr variants eliminate Cys residues that are important for disulfide bond formation in the EGF-1 and EGF-2 domains (<xref ref-type="fig" rid="pone-0035773-g002">Figure 2Aâ2B</xref>), respectively. These mutations might result in the production of an aberrant multimer or high molecular weight complex <xref rid="pone.0035773-Beckmann1" ref-type="bibr">[36]</xref>. Variants in the enzymatic serine protease domain (p.Ser223Arg, p.Asp297His, p.Glu327Val, and p.Val420Leu) are located adjacent to either the serine protease active site triad or the substrate binding region (<xref ref-type="fig" rid="pone-0035773-g002">Figure 2Câ2H</xref>). These substitutions may impair the structural integrity and stability of the heavy chain and attenuate the catalytic activity of the protein <xref rid="pone.0035773-Greengard1" ref-type="bibr">[37]</xref>.</p>
      <p>The three novel null mutations (c.237+5G&gt;A, c.349_352del, c.719dupG) are evidently detrimental because they either impair mRNA splicing by disrupting the consensus sequences of the exon-intron boundary or produce a premature stop codon. Abnormal translation products may not be stable <italic>in vivo</italic> due to nonsense-mediated mRNA decay <xref rid="pone.0035773-Singh1" ref-type="bibr">[38]</xref>, <xref rid="pone.0035773-Barash1" ref-type="bibr">[39]</xref>. The c.*73C&gt;T mutation is located in the untranslated region of the last exon. The 3â²-untranslated region is essential for the posttranscriptional regulation of mRNA expression. Mutations in this region almost always reduce the stability and half-life of transcripts <xref rid="pone.0035773-Conne1" ref-type="bibr">[40]</xref>, <xref rid="pone.0035773-Mignone1" ref-type="bibr">[41]</xref>.</p>
      <p>The recurrent c.565C&gt;T variant (p.Arg189Trp, R147W, or rs146922325:C&gt;T) was identified in 17 probands, accounting for half of the cases of PC deficiency. The retrospective family study showed that first-degree relatives bearing this variant had an 8.8-fold increased risk of venous thrombosis. The statistical power of this analysis is approximately 0.989, with a type I error probability of 0.01. However, the confidence intervals was wide due to the small number of family members enrolled and the low incidence of thrombosis in the non-carrier group. A larger prospective study will be required to confirm our observations.</p>
      <p>The R147W substitution is adjacent to the EGF-2 domain at the C-terminal of the light chain and may impair the interaction of PC with other molecular such as thrombin-thrombomodulin complex, substrate, or phospholipid <xref rid="pone.0035773-Wacey1" ref-type="bibr">[42]</xref>. Further functional studies are required to define the deleterious effect of this mutation on the activation of PC, the inactivation of FVa by APC, and the cytoprotective role of APC. This missense mutation was first described in a family with PC deficiency as well as an asymptomatic individual in 1995 <xref rid="pone.0035773-Reitsma2" ref-type="bibr">[34]</xref>, <xref rid="pone.0035773-Tait1" ref-type="bibr">[43]</xref>. Consistent with previous studies, our analysis showed that the heterozygous state is associated with decreased functional activity (40.4â62.3 U/dl) and a relatively normal antigen level (68.7â83.0 U/dl, <xref ref-type="fig" rid="pone-0035773-g004">Figure 4</xref>), indicating type II PC deficiency. This variant is believed to be a rare mutation and the corresponding minor allele frequency in dbSNP is 0.000. Because its prevalence, a case-control study was further conducted. This variant was also present in 9 out of the 1031 control subjects (0.87%) and was significantly associated with VT risk. The statistical power of our analysis is approximately 0.999, with a type I error probability of 0.01. In combination with the genotyping data from the 492 DNA samples from Shanghai, the c.565C&gt;T variant was present in approximately 0.85% (95%CIâ=â0.38%â1.31%) of the general population. The carrier rate of this variant allele is relatively lower than that of factor V Leiden (5%â10%) and prothrombin G20210A (2%â4%), two polymorphisms that confer moderate predisposition to VT in Whites <xref rid="pone.0035773-Dahlbck3" ref-type="bibr">[44]</xref>. However, it is more common than the antithrombin Cambridge II variant (approximately 0.2%) <xref rid="pone.0035773-Corral1" ref-type="bibr">[45]</xref> and other rare but severe anticoagulant protein (AT, PC, and PS) mutations. One previous study <xref rid="pone.0035773-Zhu1" ref-type="bibr">[46]</xref> showed that the estimated prevalence of protein C deficiency in the general Chinese population is approximately 0.29%. In their study, only subjects with PC activity below the 1<sup>st</sup> percentile were selected for DNA mutation analysis and considered to have âPC deficiencyâ. Subjects with a PC level between the 1<sup>st</sup> and 2.5<sup>th</sup> percentiles might also have a genetic defect. Therefore, these genetic variants might have been missed. The <italic>PROC</italic> c.565C&gt;T was one such of the missed mutations. When this moderate mutation is taken into account, however, it is clear that PC deficiency has been underestimated and may be more frequent in the Chinese population than in Japanese or European populations <xref rid="pone.0035773-Miletich1" ref-type="bibr">[47]</xref>, <xref rid="pone.0035773-Sakata1" ref-type="bibr">[48]</xref>.</p>
      <fig id="pone-0035773-g004" position="float">
        <object-id pub-id-type="doi">10.1371/journal.pone.0035773.g004</object-id>
        <label>Figure 4</label>
        <caption>
          <title>Plasma protein C level of the <italic>PROC</italic> c.565C&gt;T heterozygous subjects and normal individuals.</title>
          <p>The mean, median, interquartile range, and range of protein C levels (activity and antigen) are shown. Gray box, C/T genotype (nâ=â17). White box, C/C wild-type (nâ=â20).</p>
        </caption>
        <graphic xlink:href="pone.0035773.g004"/>
      </fig>
      <p>In conclusion, we investigated the genetic background of PC deficiency in the Chinese population for the first time and identified one recurrent variant as well as 17 other mutations. The NM_000312.3:c.565C&gt;T mutation is not only the most frequent variant for PC deficiency but also a significant risk factor for venous thrombosis in Chinese individuals. Although this variant was identified about 16 years ago as a rare mutation in Western populations, its high prevalence and potential clinical significance in the Chinese population was not appreciated until now. The prevalence of and the thrombotic risk associated with this mutation in other populations (especially other Asian populations) should be further evaluated. This genetic detection may be included in the routine thrombophilia screening, and carriers of this variant may benefit from early diagnosis and better prevention <xref rid="pone.0035773-Yang1" ref-type="bibr">[49]</xref>.</p>
    </sec>
  </body>
  <back>
    <ack>
      <p>We are indebted to all of the participants in this study and medical assistants of our hospital. Our special thanks go to the Department of Vascular Surgery (Union Hospital), the Ministry of Education Key Lab for Environment and Health (Tongji Medical College), and the co-workers at Shanghai Dongfang Hospital.</p>
    </ack>
    <fn-group>
      <fn fn-type="COI-statement">
        <p><bold>Competing Interests: </bold>The authors have declared that no competing interests exist.</p>
      </fn>
      <fn fn-type="financial-disclosure">
        <p><bold>Funding: </bold>This work was supported by the National Basic Scientific Research Program of China (973 Program, No. 2007 CB935803), the National Natural Sciences Foundation of China (No. 30825018), and the State Ministry of Health Key Clinical Construction Project (2010 No. 58). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.</p>
      </fn>
    </fn-group>
    <ref-list>
      <title>References</title>
      <ref id="pone.0035773-Esmon1">
        <label>1</label>
        <element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Esmon</surname><given-names>CT</given-names></name></person-group>
<year>2003</year>
<article-title>The protein C pathway.</article-title>
<source>Chest</source>
<volume>124</volume>
<fpage>26S</fpage>
<lpage>32S</lpage>
<pub-id pub-id-type="pmid">12970121</pub-id></element-citation>
      </ref>
      <ref id="pone.0035773-Dahlbck1">
        <label>2</label>
        <element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>DahlbÃ¤ck</surname><given-names>B</given-names></name><name><surname>Villoutreix</surname><given-names>BO</given-names></name></person-group>
<year>2003</year>
<article-title>Molecular recognition in the protein C anticoagulant pathway.</article-title>
<source>J Thromb Haemost</source>
<volume>1</volume>
<fpage>1525</fpage>
<lpage>34</lpage>
<pub-id pub-id-type="pmid">12871288</pub-id></element-citation>
      </ref>
      <ref id="pone.0035773-Marlar1">
        <label>3</label>
        <element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Marlar</surname><given-names>RA</given-names></name><name><surname>Kleiss</surname><given-names>AJ</given-names></name><name><surname>Griffin</surname><given-names>JH</given-names></name></person-group>
<year>1982</year>
<article-title>Mechanism of action of human activated protein C, a thrombin-dependent anticoagulant enzyme.</article-title>
<source>Blood</source>
<volume>59</volume>
<fpage>1067</fpage>
<lpage>72</lpage>
<pub-id pub-id-type="pmid">6803853</pub-id></element-citation>
      </ref>
      <ref id="pone.0035773-Fisher1">
        <label>4</label>
        <element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Fisher</surname><given-names>CL</given-names></name><name><surname>Greengard</surname><given-names>JS</given-names></name><name><surname>Griffin</surname><given-names>JH</given-names></name></person-group>
<year>1994</year>
<article-title>Models of the serine protease domain of the human antithrombotic plasma factor activated protein C and its zymogen.</article-title>
<source>Protein Sci</source>
<volume>3</volume>
<fpage>588</fpage>
<lpage>99</lpage>
<pub-id pub-id-type="pmid">8003977</pub-id></element-citation>
      </ref>
      <ref id="pone.0035773-Perera1">
        <label>5</label>
        <element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Perera</surname><given-names>L</given-names></name><name><surname>Foley</surname><given-names>C</given-names></name><name><surname>Darden</surname><given-names>TA</given-names></name><name><surname>Stafford</surname><given-names>D</given-names></name><name><surname>Mather</surname><given-names>T</given-names></name><etal/></person-group>
<year>2000</year>
<article-title>Modeling zymogen protein C.</article-title>
<source>Biophys J</source>
<volume>79</volume>
<fpage>2925</fpage>
<lpage>43</lpage>
<pub-id pub-id-type="pmid">11106601</pub-id></element-citation>
      </ref>
      <ref id="pone.0035773-Kisiel1">
        <label>6</label>
        <element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Kisiel</surname><given-names>W</given-names></name></person-group>
<year>1979</year>
<article-title>Human plasma protein C: isolation, characterization, and mechanism of activation by alpha-thrombin.</article-title>
<source>J Clin Invest</source>
<volume>64</volume>
<fpage>761</fpage>
<lpage>9</lpage>
<pub-id pub-id-type="pmid">468991</pub-id></element-citation>
      </ref>
      <ref id="pone.0035773-Dahlbck2">
        <label>7</label>
        <element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>DahlbÃ¤ck</surname><given-names>B</given-names></name><name><surname>Villoutreix</surname><given-names>BO</given-names></name></person-group>
<year>2005</year>
<article-title>Regulation of blood coagulation by the protein C anticoagulant pathway. Novel insights into structure-function relationships andmolecular recognition.</article-title>
<source>Arterioscler Thromb Vasc Biol</source>
<volume>25</volume>
<fpage>1311</fpage>
<lpage>20</lpage>
<pub-id pub-id-type="pmid">15860736</pub-id></element-citation>
      </ref>
      <ref id="pone.0035773-Mosnier1">
        <label>8</label>
        <element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Mosnier</surname><given-names>LO</given-names></name><name><surname>Zlokovic</surname><given-names>BV</given-names></name><name><surname>Griffin</surname><given-names>JH</given-names></name></person-group>
<year>2007</year>
<article-title>The cytoprotective protein C pathway.</article-title>
<source>Blood</source>
<volume>109</volume>
<fpage>3161</fpage>
<lpage>72</lpage>
<pub-id pub-id-type="pmid">17110453</pub-id></element-citation>
      </ref>
      <ref id="pone.0035773-Foster1">
        <label>9</label>
        <element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Foster</surname><given-names>DC</given-names></name><name><surname>Yoshitake</surname><given-names>S</given-names></name><name><surname>Davie</surname><given-names>EW</given-names></name></person-group>
<year>1985</year>
<article-title>The nucleotide sequence of the gene for human protein C.</article-title>
<source>Proc Natl Acad Sci U S A</source>
<volume>82</volume>
<fpage>4673</fpage>
<lpage>7</lpage>
<pub-id pub-id-type="pmid">2991887</pub-id></element-citation>
      </ref>
      <ref id="pone.0035773-Plutzky1">
        <label>10</label>
        <element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Plutzky</surname><given-names>J</given-names></name><name><surname>Hoskins</surname><given-names>JA</given-names></name><name><surname>Long</surname><given-names>GL</given-names></name><name><surname>Crabtree</surname><given-names>GR</given-names></name></person-group>
<year>1986</year>
<article-title>Evolution and organization of the human protein C gene.</article-title>
<source>Proc Natl Acad Sci U S A</source>
<volume>83</volume>
<fpage>546</fpage>
<lpage>50</lpage>
<pub-id pub-id-type="pmid">3511471</pub-id></element-citation>
      </ref>
      <ref id="pone.0035773-Bertina1">
        <label>11</label>
        <element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Bertina</surname><given-names>RM</given-names></name><name><surname>Koeleman</surname><given-names>BP</given-names></name><name><surname>Koster</surname><given-names>T</given-names></name><name><surname>Rosendaal</surname><given-names>FR</given-names></name><name><surname>Dirven</surname><given-names>RJ</given-names></name><etal/></person-group>
<year>1994</year>
<article-title>Mutation in blood coagulation factor V associated with resistance to activated protein C.</article-title>
<source>Nature</source>
<volume>369</volume>
<fpage>64</fpage>
<lpage>7</lpage>
<pub-id pub-id-type="pmid">8164741</pub-id></element-citation>
      </ref>
      <ref id="pone.0035773-Poort1">
        <label>12</label>
        <element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Poort</surname><given-names>SR</given-names></name><name><surname>Rosendaal</surname><given-names>FR</given-names></name><name><surname>Reitsma</surname><given-names>PH</given-names></name><name><surname>Bertina</surname><given-names>RM</given-names></name></person-group>
<year>1996</year>
<article-title>A common genetic variation in the 3â²- untranslated region of the prothrombin gene is associated with elevated plasma prothrombin levels and an increase in venous thrombosis.</article-title>
<source>Blood</source>
<volume>88</volume>
<fpage>3698</fpage>
<lpage>703</lpage>
<pub-id pub-id-type="pmid">8916933</pub-id></element-citation>
      </ref>
      <ref id="pone.0035773-Bounameaux1">
        <label>13</label>
        <element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Bounameaux</surname><given-names>H</given-names></name><name><surname>Rosendaal</surname><given-names>FR</given-names></name></person-group>
<year>2011</year>
<article-title>Venous thromboembolism: why does ethnicity matter?</article-title>
<source>Circulation</source>
<volume>123</volume>
<fpage>2189</fpage>
<lpage>91</lpage>
<pub-id pub-id-type="pmid">21555708</pub-id></element-citation>
      </ref>
      <ref id="pone.0035773-Roberts1">
        <label>14</label>
        <element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Roberts</surname><given-names>LN</given-names></name><name><surname>Patel</surname><given-names>RK</given-names></name><name><surname>Arya</surname><given-names>R</given-names></name></person-group>
<year>2009</year>
<article-title>Venous thromboembolism and ethnicity.</article-title>
<source>Br J Haematol</source>
<volume>146</volume>
<fpage>369</fpage>
<lpage>83</lpage>
<pub-id pub-id-type="pmid">19552721</pub-id></element-citation>
      </ref>
      <ref id="pone.0035773-Suehisa1">
        <label>15</label>
        <element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Suehisa</surname><given-names>E</given-names></name><name><surname>Nomura</surname><given-names>T</given-names></name><name><surname>Kawasaki</surname><given-names>T</given-names></name><name><surname>Kanakura</surname><given-names>Y</given-names></name></person-group>
<year>2001</year>
<article-title>Frequency of natural coagulation inhibitor (antithrombin III, protein C and protein S) deficiencies in Japanese patients with spontaneous deep vein thrombosis.</article-title>
<source>Blood Coagul Fibrinolysis</source>
<volume>12</volume>
<fpage>95</fpage>
<lpage>9</lpage>
<pub-id pub-id-type="pmid">11302483</pub-id></element-citation>
      </ref>
      <ref id="pone.0035773-Koster1">
        <label>16</label>
        <element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Koster</surname><given-names>T</given-names></name><name><surname>Rosendaal</surname><given-names>FR</given-names></name><name><surname>BriÃ«t</surname><given-names>E</given-names></name><name><surname>van der Meer</surname><given-names>FJ</given-names></name><name><surname>Colly</surname><given-names>LP</given-names></name><etal/></person-group>
<year>1995</year>
<article-title>Protein C deficiency in a controlled series of unselected outpatients: an infrequent but clear risk factor for venous thrombosis (Leiden Thrombophilia Study).</article-title>
<source>Blood</source>
<volume>85</volume>
<fpage>2756</fpage>
<lpage>61</lpage>
<pub-id pub-id-type="pmid">7742536</pub-id></element-citation>
      </ref>
      <ref id="pone.0035773-Millar1">
        <label>17</label>
        <element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Millar</surname><given-names>DS</given-names></name><name><surname>Johansen</surname><given-names>B</given-names></name><name><surname>Berntorp</surname><given-names>E</given-names></name><name><surname>Minford</surname><given-names>A</given-names></name><name><surname>Bolton-Maggs</surname><given-names>P</given-names></name><etal/></person-group>
<year>2000</year>
<article-title>Molecular genetic analysis of severe protein C deficiency.</article-title>
<source>Hum Genet</source>
<volume>106</volume>
<fpage>646</fpage>
<lpage>53</lpage>
<pub-id pub-id-type="pmid">10942114</pub-id></element-citation>
      </ref>
      <ref id="pone.0035773-Allaart1">
        <label>18</label>
        <element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Allaart</surname><given-names>CF</given-names></name><name><surname>Poort</surname><given-names>SR</given-names></name><name><surname>Rosendaal</surname><given-names>FR</given-names></name><name><surname>Reitsma</surname><given-names>PH</given-names></name><name><surname>Bertina</surname><given-names>RM</given-names></name><etal/></person-group>
<year>1993</year>
<article-title>Increased risk of venous thrombosis in carriers of hereditary protein C deficiency defect.</article-title>
<source>Lancet</source>
<volume>341</volume>
<fpage>134</fpage>
<lpage>8</lpage>
<pub-id pub-id-type="pmid">8093743</pub-id></element-citation>
      </ref>
      <ref id="pone.0035773-denDunnen1">
        <label>19</label>
        <element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>den Dunnen</surname><given-names>JT</given-names></name><name><surname>Antonarakis</surname><given-names>SE</given-names></name></person-group>
<year>2000</year>
<article-title>Mutation nomenclature extensions and suggestions to describe complex mutations: a discussion.</article-title>
<source>Hum Mutat</source>
<volume>15</volume>
<fpage>7</fpage>
<lpage>12</lpage>
<pub-id pub-id-type="pmid">10612815</pub-id></element-citation>
      </ref>
      <ref id="pone.0035773-Taschner1">
        <label>20</label>
        <element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Taschner</surname><given-names>PE</given-names></name><name><surname>den Dunnen</surname><given-names>JT</given-names></name></person-group>
<year>2011</year>
<article-title>Describing structural changes by extending HGVS sequence variation nomenclature.</article-title>
<source>Hum Mutat</source>
<volume>32</volume>
<fpage>507</fpage>
<lpage>11</lpage>
<pub-id pub-id-type="pmid">21309030</pub-id></element-citation>
      </ref>
      <ref id="pone.0035773-Wildeman1">
        <label>21</label>
        <element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Wildeman</surname><given-names>M</given-names></name><name><surname>van Ophuizen</surname><given-names>E</given-names></name><name><surname>den Dunnen</surname><given-names>JT</given-names></name><name><surname>Taschner</surname><given-names>PE</given-names></name></person-group>
<year>2008</year>
<article-title>Improving sequence variant descriptions in mutation databases and literature using the Mutalyzer sequence variation nomenclature checker.</article-title>
<source>Hum Mutat</source>
<volume>29</volume>
<fpage>6</fpage>
<lpage>13</lpage>
<pub-id pub-id-type="pmid">18000842</pub-id></element-citation>
      </ref>
      <ref id="pone.0035773-Kumar1">
        <label>22</label>
        <element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Kumar</surname><given-names>P</given-names></name><name><surname>Henikoff</surname><given-names>S</given-names></name><name><surname>Ng</surname><given-names>PC</given-names></name></person-group>
<year>2009</year>
<article-title>Predicting the effects of coding non-synonymous variants on protein function using the SIFT algorithm.</article-title>
<source>Nat Protoc</source>
<volume>4</volume>
<fpage>1073</fpage>
<lpage>81</lpage>
<pub-id pub-id-type="pmid">19561590</pub-id></element-citation>
      </ref>
      <ref id="pone.0035773-Adzhubei1">
        <label>23</label>
        <element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Adzhubei</surname><given-names>IA</given-names></name><name><surname>Schmidt</surname><given-names>S</given-names></name><name><surname>Peshkin</surname><given-names>L</given-names></name><name><surname>Ramensky</surname><given-names>VE</given-names></name><name><surname>Gerasimova</surname><given-names>A</given-names></name><etal/></person-group>
<year>2010</year>
<article-title>A method and server for predicting damaging missense mutations.</article-title>
<source>Nat Methods</source>
<volume>7</volume>
<fpage>248</fpage>
<lpage>9</lpage>
<pub-id pub-id-type="pmid">20354512</pub-id></element-citation>
      </ref>
      <ref id="pone.0035773-Wang1">
        <label>24</label>
        <element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Wang</surname><given-names>M</given-names></name><name><surname>MarÃ­n</surname><given-names>A</given-names></name></person-group>
<year>2006</year>
<article-title>Characterization and prediction of alternative splice sites.</article-title>
<source>Gene</source>
<volume>366</volume>
<fpage>219</fpage>
<lpage>27</lpage>
<pub-id pub-id-type="pmid">16226402</pub-id></element-citation>
      </ref>
      <ref id="pone.0035773-Dogan1">
        <label>25</label>
        <element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Dogan</surname><given-names>RI</given-names></name><name><surname>Getoor</surname><given-names>L</given-names></name><name><surname>Wilbur</surname><given-names>WJ</given-names></name><name><surname>Mount</surname><given-names>SM</given-names></name></person-group>
<year>2007</year>
<article-title>SplicePortâan interactive splice-site analysis tool.</article-title>
<source>Nucleic Acids Res</source>
<volume>35</volume>
<fpage>W285</fpage>
<lpage>91</lpage>
<pub-id pub-id-type="pmid">17576680</pub-id></element-citation>
      </ref>
      <ref id="pone.0035773-Kiefer1">
        <label>26</label>
        <element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Kiefer</surname><given-names>F</given-names></name><name><surname>Arnold</surname><given-names>K</given-names></name><name><surname>KÃ¼nzli</surname><given-names>M</given-names></name><name><surname>Bordoli</surname><given-names>L</given-names></name><name><surname>Schwede</surname><given-names>T</given-names></name></person-group>
<year>2009</year>
<article-title>The SWISS-MODEL Repository and associated resources.</article-title>
<source>Nucleic Acids Res</source>
<volume>37</volume>
<fpage>D387</fpage>
<lpage>92</lpage>
<pub-id pub-id-type="pmid">18931379</pub-id></element-citation>
      </ref>
      <ref id="pone.0035773-Schmidt1">
        <label>27</label>
        <element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Schmidt</surname><given-names>AE</given-names></name><name><surname>Padmanabhan</surname><given-names>K</given-names></name><name><surname>Underwood</surname><given-names>MC</given-names></name><name><surname>Bode</surname><given-names>W</given-names></name><name><surname>Mather</surname><given-names>T</given-names></name><etal/></person-group>
<year>2002</year>
<article-title>Thermodynamic linkage between the S1 site, the Na+ site, and the Ca2+ site in the protease domain of human activated protein C (APC). Sodium ion in the APC crystal structure is coordinated to four carbonyl groups from two separate loops.</article-title>
<source>J Biol Chem</source>
<volume>277</volume>
<fpage>28987</fpage>
<lpage>95</lpage>
<pub-id pub-id-type="pmid">12029084</pub-id></element-citation>
      </ref>
      <ref id="pone.0035773-Dupont1">
        <label>28</label>
        <element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Dupont</surname><given-names>WD</given-names></name><name><surname>Plummer</surname><given-names>WD</given-names><suffix>Jr</suffix></name></person-group>
<year>1990</year>
<article-title>Power and sample size calculations. A review and computer program.</article-title>
<source>Control Clin Trials</source>
<volume>11</volume>
<fpage>116</fpage>
<lpage>28</lpage>
<pub-id pub-id-type="pmid">2161310</pub-id></element-citation>
      </ref>
      <ref id="pone.0035773-Reitsma1">
        <label>29</label>
        <element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Reitsma</surname><given-names>PH</given-names></name><name><surname>Poort</surname><given-names>SR</given-names></name><name><surname>Allaart</surname><given-names>CF</given-names></name><name><surname>BriÃ«t</surname><given-names>E</given-names></name><name><surname>Bertina</surname><given-names>RM</given-names></name></person-group>
<year>1991</year>
<article-title>The spectrum of genetic defects in a panel of 40 Dutch families with symptomatic protein C deficiency type I: heterogeneity and founder effects.</article-title>
<source>Blood</source>
<volume>78</volume>
<fpage>890</fpage>
<lpage>4</lpage>
<pub-id pub-id-type="pmid">1868249</pub-id></element-citation>
      </ref>
      <ref id="pone.0035773-Gandrille1">
        <label>30</label>
        <element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Gandrille</surname><given-names>S</given-names></name><name><surname>Aiach</surname><given-names>M</given-names></name></person-group>
<year>1995</year>
<article-title>Identification of mutations in 90 of 121 consecutive symptomatic French patients with a type I protein C deficiency. The French INSERM Network on Molecular Abnormalities Responsible for Protein C and Protein S deficiencies.</article-title>
<source>Blood</source>
<volume>86</volume>
<fpage>2598</fpage>
<lpage>605</lpage>
<pub-id pub-id-type="pmid">7670104</pub-id></element-citation>
      </ref>
      <ref id="pone.0035773-Grundy1">
        <label>31</label>
        <element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Grundy</surname><given-names>CB</given-names></name><name><surname>Schulman</surname><given-names>S</given-names></name><name><surname>Tengborn</surname><given-names>L</given-names></name><name><surname>Kakkar</surname><given-names>VV</given-names></name><name><surname>Cooper</surname><given-names>DN</given-names></name></person-group>
<year>1992</year>
<article-title>Two different missense mutations at Arg 178 of the protein C (PROC) gene causing recurrent venous thrombosis.</article-title>
<source>Hum Genet</source>
<volume>89</volume>
<fpage>685</fpage>
<lpage>6</lpage>
<pub-id pub-id-type="pmid">1511989</pub-id></element-citation>
      </ref>
      <ref id="pone.0035773-Poort2">
        <label>32</label>
        <element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Poort</surname><given-names>SR</given-names></name><name><surname>Pabinger-Fasching</surname><given-names>I</given-names></name><name><surname>Mannhalter</surname><given-names>C</given-names></name><name><surname>Reitsma</surname><given-names>PH</given-names></name><name><surname>Bertina</surname><given-names>RM</given-names></name></person-group>
<year>1993</year>
<article-title>Twelve novel and two recurrent mutations in 14 Austrian families with hereditary protein C deficiency.</article-title>
<source>Blood Coagul Fibrinolysis</source>
<volume>4</volume>
<fpage>273</fpage>
<lpage>80</lpage>
<pub-id pub-id-type="pmid">8499565</pub-id></element-citation>
      </ref>
      <ref id="pone.0035773-Miyata1">
        <label>33</label>
        <element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Miyata</surname><given-names>T</given-names></name><name><surname>Sakata</surname><given-names>T</given-names></name><name><surname>Zheng</surname><given-names>YZ</given-names></name><name><surname>Tsukamoto</surname><given-names>H</given-names></name><name><surname>Umeyama</surname><given-names>H</given-names></name><etal/></person-group>
<year>1996</year>
<article-title>Genetic characterization of protein C deficiency in Japanese subjects using a rapid and nonradioactive method for single-stand conformational polymorphism analysis and a model building.</article-title>
<source>Thromb Haemost</source>
<volume>76</volume>
<fpage>302</fpage>
<lpage>11</lpage>
<pub-id pub-id-type="pmid">8883262</pub-id></element-citation>
      </ref>
      <ref id="pone.0035773-Reitsma2">
        <label>34</label>
        <element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Reitsma</surname><given-names>PH</given-names></name><name><surname>Bernardi</surname><given-names>F</given-names></name><name><surname>Doig</surname><given-names>RG</given-names></name><name><surname>Gandrille</surname><given-names>S</given-names></name><name><surname>Greengard</surname><given-names>JS</given-names></name><etal/></person-group>
<year>1995</year>
<article-title>Protein C deficiency: a database of mutations, 1995 update. On behalf of the Subcommittee on Plasma Coagulation Inhibitors of the Scientific and Standardization Committee of the ISTH.</article-title>
<source>Thromb Haemost</source>
<volume>73</volume>
<fpage>876</fpage>
<lpage>89</lpage>
<pub-id pub-id-type="pmid">7482420</pub-id></element-citation>
      </ref>
      <ref id="pone.0035773-Foster2">
        <label>35</label>
        <element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Foster</surname><given-names>DC</given-names></name><name><surname>Rudinski</surname><given-names>MS</given-names></name><name><surname>Schach</surname><given-names>BG</given-names></name><name><surname>Berkner</surname><given-names>KL</given-names></name><name><surname>Kumar</surname><given-names>AA</given-names></name><etal/></person-group>
<year>1987</year>
<article-title>Propeptide of human protein C is necessary for gamma-carboxylation.</article-title>
<source>Biochemistry</source>
<volume>26</volume>
<fpage>7003</fpage>
<lpage>11</lpage>
<pub-id pub-id-type="pmid">3427056</pub-id></element-citation>
      </ref>
      <ref id="pone.0035773-Beckmann1">
        <label>36</label>
        <element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Beckmann</surname><given-names>RJ</given-names></name><name><surname>Schmidt</surname><given-names>RJ</given-names></name><name><surname>Santerre</surname><given-names>RF</given-names></name><name><surname>Plutzky</surname><given-names>J</given-names></name><name><surname>Crabtree</surname><given-names>GR</given-names></name><etal/></person-group>
<year>1985</year>
<article-title>The structure and evolution of a 461 amino acid human protein C precursor and its messenger RNA, based upon the DNA sequence of cloned human liver cDNAs.</article-title>
<source>Nucleic Acids Res</source>
<volume>13</volume>
<fpage>5233</fpage>
<lpage>47</lpage>
<pub-id pub-id-type="pmid">2991859</pub-id></element-citation>
      </ref>
      <ref id="pone.0035773-Greengard1">
        <label>37</label>
        <element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Greengard</surname><given-names>JS</given-names></name><name><surname>Fisher</surname><given-names>CL</given-names></name><name><surname>Villoutreix</surname><given-names>B</given-names></name><name><surname>Griffin</surname><given-names>JH</given-names></name></person-group>
<year>1994</year>
<article-title>Structural basis for type I and type II deficiencies of antithrombotic plasma protein C: patterns revealed by three-dimensional molecular modelling of mutations of the protease domain.</article-title>
<source>Proteins</source>
<volume>18</volume>
<fpage>367</fpage>
<lpage>80</lpage>
<pub-id pub-id-type="pmid">8208728</pub-id></element-citation>
      </ref>
      <ref id="pone.0035773-Singh1">
        <label>38</label>
        <element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Singh</surname><given-names>G</given-names></name><name><surname>Lykke-Andersen</surname><given-names>J</given-names></name></person-group>
<year>2003</year>
<article-title>New insights into the formation of active nonsense-mediated decay complexes.</article-title>
<source>Trends Biochem Sci</source>
<volume>28</volume>
<fpage>464</fpage>
<lpage>6</lpage>
<pub-id pub-id-type="pmid">13678954</pub-id></element-citation>
      </ref>
      <ref id="pone.0035773-Barash1">
        <label>39</label>
        <element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Barash</surname><given-names>Y</given-names></name><name><surname>Calarco</surname><given-names>JA</given-names></name><name><surname>Gao</surname><given-names>W</given-names></name><name><surname>Pan</surname><given-names>Q</given-names></name><name><surname>Wang</surname><given-names>X</given-names></name><etal/></person-group>
<year>2010</year>
<article-title>Deciphering the splicing code.</article-title>
<source>Nature</source>
<volume>465</volume>
<fpage>53</fpage>
<lpage>9</lpage>
<pub-id pub-id-type="pmid">20445623</pub-id></element-citation>
      </ref>
      <ref id="pone.0035773-Conne1">
        <label>40</label>
        <element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Conne</surname><given-names>B</given-names></name><name><surname>Stutz</surname><given-names>A</given-names></name><name><surname>Vassalli</surname><given-names>JD</given-names></name></person-group>
<year>2000</year>
<article-title>The 3â² untranslated region of messenger RNA: A molecular âhotspotâ for pathology?</article-title>
<source>Nat Med</source>
<volume>6</volume>
<fpage>637</fpage>
<lpage>41</lpage>
<pub-id pub-id-type="pmid">10835679</pub-id></element-citation>
      </ref>
      <ref id="pone.0035773-Mignone1">
        <label>41</label>
        <element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Mignone</surname><given-names>F</given-names></name><name><surname>Gissi</surname><given-names>C</given-names></name><name><surname>Liuni</surname><given-names>S</given-names></name><name><surname>Pesole</surname><given-names>G</given-names></name></person-group>
<year>2001</year>
<article-title>Untranslated regions of mRNAs.</article-title>
<source>Genome Biol</source>
<volume>3</volume>
<fpage>REVIEWS0004</fpage>
</element-citation>
      </ref>
      <ref id="pone.0035773-Wacey1">
        <label>42</label>
        <element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Wacey</surname><given-names>AI</given-names></name><name><surname>Pemberton</surname><given-names>S</given-names></name><name><surname>Cooper</surname><given-names>DN</given-names></name><name><surname>Kakkar</surname><given-names>VV</given-names></name><name><surname>Tuddenham</surname><given-names>EG</given-names></name></person-group>
<year>1993</year>
<article-title>A molecular model of the serine protease domain of activated protein C: application to the study of missense mutations causing protein C deficiency.</article-title>
<source>Br J Haematol</source>
<volume>84</volume>
<fpage>290</fpage>
<lpage>300</lpage>
<pub-id pub-id-type="pmid">8398833</pub-id></element-citation>
      </ref>
      <ref id="pone.0035773-Tait1">
        <label>43</label>
        <element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Tait</surname><given-names>RC</given-names></name><name><surname>Walker</surname><given-names>ID</given-names></name><name><surname>Reitsma</surname><given-names>PH</given-names></name><name><surname>Islam</surname><given-names>SI</given-names></name><name><surname>McCall</surname><given-names>F</given-names></name><etal/></person-group>
<year>1995</year>
<article-title>Prevalence of protein C deficiency in the healthy population.</article-title>
<source>Thromb Haemost</source>
<volume>73</volume>
<fpage>87</fpage>
<lpage>93</lpage>
<pub-id pub-id-type="pmid">7740502</pub-id></element-citation>
      </ref>
      <ref id="pone.0035773-Dahlbck3">
        <label>44</label>
        <element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>DahlbÃ¤ck</surname><given-names>B</given-names></name></person-group>
<year>2008</year>
<article-title>Advances in understanding pathogenic mechanisms of thrombophilic disorders.</article-title>
<source>Blood</source>
<volume>112</volume>
<fpage>19</fpage>
<lpage>27</lpage>
<pub-id pub-id-type="pmid">18574041</pub-id></element-citation>
      </ref>
      <ref id="pone.0035773-Corral1">
        <label>45</label>
        <element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Corral</surname><given-names>J</given-names></name><name><surname>Hernandez-Espinosa</surname><given-names>D</given-names></name><name><surname>Soria</surname><given-names>JM</given-names></name><name><surname>Gonzalez-Conejero</surname><given-names>R</given-names></name><name><surname>Ordonez</surname><given-names>A</given-names></name><etal/></person-group>
<year>2007</year>
<article-title>Antithrombin Cambridge II (A384S): an underestimated genetic risk factor for venous thrombosis.</article-title>
<source>Blood</source>
<volume>109</volume>
<fpage>4258</fpage>
<lpage>63</lpage>
<pub-id pub-id-type="pmid">17244682</pub-id></element-citation>
      </ref>
      <ref id="pone.0035773-Zhu1">
        <label>46</label>
        <element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Zhu</surname><given-names>T</given-names></name><name><surname>Ding</surname><given-names>Q</given-names></name><name><surname>Bai</surname><given-names>X</given-names></name><name><surname>Wang</surname><given-names>X</given-names></name><name><surname>Kaguelidou</surname><given-names>F</given-names></name><etal/></person-group>
<year>2011</year>
<article-title>Normal ranges and genetic variants of antithrombin, protein C and protein S in the general Chinese population. Results of the Chinese Hemostasis Investigation on Natural Anticoagulants Study I Group.</article-title>
<source>Haematologica</source>
<volume>96</volume>
<fpage>1033</fpage>
<lpage>40</lpage>
<pub-id pub-id-type="pmid">21486865</pub-id></element-citation>
      </ref>
      <ref id="pone.0035773-Miletich1">
        <label>47</label>
        <element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Miletich</surname><given-names>J</given-names></name><name><surname>Sherman</surname><given-names>L</given-names></name><name><surname>Broze</surname><given-names>G</given-names><suffix>Jr</suffix></name></person-group>
<year>1987</year>
<article-title>Absence of thrombosis in subjects with heterozygous protein C deficiency.</article-title>
<source>N Engl J Med</source>
<volume>317</volume>
<fpage>991</fpage>
<lpage>6</lpage>
<pub-id pub-id-type="pmid">3657866</pub-id></element-citation>
      </ref>
      <ref id="pone.0035773-Sakata1">
        <label>48</label>
        <element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Sakata</surname><given-names>T</given-names></name><name><surname>Okamoto</surname><given-names>A</given-names></name><name><surname>Mannami</surname><given-names>T</given-names></name><name><surname>Matsuo</surname><given-names>H</given-names></name><name><surname>Miyata</surname><given-names>T</given-names></name></person-group>
<year>2004</year>
<article-title>Protein C and antithrombin deficiency are important risk factors for deep vein thrombosis in Japanese.</article-title>
<source>J Thromb Haemost</source>
<volume>2</volume>
<fpage>528</fpage>
<lpage>30</lpage>
<pub-id pub-id-type="pmid">15009480</pub-id></element-citation>
      </ref>
      <ref id="pone.0035773-Yang1">
        <label>49</label>
        <element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Yang</surname><given-names>Y</given-names></name><name><surname>Liang</surname><given-names>L</given-names></name><name><surname>Zhai</surname><given-names>Z</given-names></name><name><surname>He</surname><given-names>H</given-names></name><name><surname>Xie</surname><given-names>W</given-names></name><etal/></person-group>
<year>2011</year>
<article-title>Pulmonary Embolism Incidence and Fatality Trends in Chinese Hospitals from 1997 to 2008: A Multicenter Registration Study.</article-title>
<source>PLoS One</source>
<volume>6</volume>
<fpage>e26861</fpage>
<pub-id pub-id-type="pmid">22069474</pub-id></element-citation>
      </ref>
    </ref-list>
  </back>
</article>

</metadata></record></GetRecord></OAI-PMH>